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Zusammenfassung 
Kürzlich wurden neun unterschiedliche Mutationen in der codierenden Region des Gens 
der humanen intestinalen Laktase-Phlorizin-Hydrolase (LPH) identifiziert. Die Mutante 
LPH-G1363S weist eine zusätzliche N-Glykosylierungsstelle auf und stellt sich bei 
Expression in COS-1-Zellen als missgefaltetes, enzymatisch nicht aktives Protein dar, 
welches das Endoplasmatische Retikulum (ER) nicht in Richtung Golgi-Apparat (GA) 
verlassen kann. Es ist eine partielle Temperatursensitivität zu beobachten, wobei 
sowohl der intrazelluläre Transport als auch die enzymatische Aktivität von LPH-
G1363S bei 20°C zum Teil wiederhergestellt werden können, nicht jedoch die korrekte 
Faltung. Des Weiteren zeigt sich, dass eine LPH-Form, welche die Mutationen G1363S 
und N1361A beinhaltet, und somit eine Re-Eliminierung der zusätzlichen N-
Glykosylierungsstelle aufweist, nicht die Eigenschaften des Wildtyp-Proteins besitzt, 
sondern die von LPH-G1363S. Daraus lässt sich ableiten, dass die zusätzliche 
Glykosyl-Gruppe nicht die Defekte von LPH-G1363S verursacht. Diese Analyse ist die 
erste Charakterisierung einer LPH-Mutante auf molekularer und subzellulärer Ebene, 
die in die Pathogenese der Congenitalen Laktase-Defizienz involviert ist und offenbart 
einen bislang unbekannten Mechanismus der Ursache von Laktose-Malabsorption. 
Der transportkompetente Protein-Vorläufer der LPH (pro-LPH) umfasst vier homologe 
Domänen. Der Einfluss jeder dieser Bereiche auf die strukturellen und funktionalen 
Eigenschaften von pro-LPH wurde durch gerichtete Umstrukturierung der Domänen-
Zusammensetzung analysiert. Dabei zeigte sich, dass das Entfernen von Domäne IV, 
welche die Laktase-Aktivität trägt, eine beschleunigte Transportkinetik nach sich zieht. 
Außerdem weist die Mutante (LPH∆4) eine verzögerte Dimerisierung im GA und eine 
reduzierte Verbundenheit mit Tween 20-resistenten Membranen im ER auf. Darüber 
hinaus kolokalisiert LPH∆4 teilweise mit dem Wildtyp-Protein in Laktase tragendenden 
apikalen Vesikeln (LAVs) aber nicht mit der Saccharase-Isomaltase (SI) in SI tragenden 
apikalen Vesikeln (SAVs). Das Fehlen von Domäne II führt zu einer verminderten 
Phlorizin-Hydrolase- und nicht mehr nachweisbaren Laktase-Aktivität, verzögerter 
Dimerisierung, jedoch kaum veränderter Transportkinetik. Die Mutanten, welchen die 
homologe Domäne III oder I fehlt sind nur teilweise gefaltet und verlassen das ER nicht. 
Die Domäne III alleine hingegen ist per se transportkompetent, enzymatisch aktiv und 
wird effizient zur apikalen Seite polarer Zellen sortiert, lässt sich jedoch nur als 
Monomer nachweisen. Daraus ergibt sich ein hierarchisches Modell der frühen 
Faltungsvorgänge der naszierenden pro-LPH, wobei der membranassoziierten Domäne 
IV bei der Protein-Zielsteuerung der pro-LPH eine regulatorische Rolle zukommt. 
Domäne III hingegen stellt die autonome Kern-Domäne des Gesamtproteins dar, 
fungiert als zweites intramolekulares Chaperon und trägt die Informationen für die 
apikale Sortierung. 
 
Schlagworte: Laktase-Phlorizin-Hydrolase, Congenitale Laktase-Defizienz, Faltung, 
intramolekulare Organisation, Zielsteuerung, Detergenz-resistente Membranen. 
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Abstract 
Recently, nine distinct mutations within the coding region of the human intestinal lactase 
phlorizin hydrolase (LPH) gene have been identified. The mutant LPH-G1363S carries 
an additional N-glycosylation site and constitutes a misfolded, enzymatically inactive 
protein, which is not able to leave the endoplasmic reticulum (ER) towards the Golgi 
apparatus (GA) when expressed in COS-1 cells. It displays partial temperature-
sensitivity, whereby its intracellular transport as well as its enzymatic activity can be 
restored in part during expression at 20°C, but correct folding can not. However, a form 
of LPH that contains the mutations G1363S and N1361A, which lead to re-elimination of 
the additional N-glycosylation site, does not display the features of wild type LPH but of 
LPH-G1363S. Thus, the additional glycosyl group is not required for the LPH-G1363S 
defects. This is the first characterization, at the molecular and subcellular levels, of a 
mutant form of LPH that is involved in the pathogenesis of congenital lactase deficiency. 
Mutant LPH accumulates predominantly in the ER but can partially mature at a 
permissive temperature; these features are unique for a protein involved in a 
carbohydrate malabsorption defect implicating LPH. 
The transport-competent protein precursor of LPH (pro-LPH) contains four homologous 
domains. The influence of each of the homologous domains on the structural and 
functional characteristics of the pro-LPH polypeptide has been analyzed by directed 
restructuring of the domain composition. Removal of domain IV, which carries the 
lactase activity, results in accelerated transport kinetics and altered patterns of 
quaternary structure and membrane association. These novel biosynthetic features of 
the mutant (LPH∆4) are directly associated with a retarded dimerisation of this mutant in 
the GA and a reduced association with Tween 20-resistant membranes in the ER. 
Furthermore, LPH∆4 co-localises partly with the wild type protein in lactase-carrying 
apical vesicles (LAVs) but not with sucrase-isomaltase in SI-carrying apical vesicles 
(SAVs). Moreover, deletion of domain II leads to a reduced phlorizin hydrolase and not 
detectable lactase activity, retarded dimerisation, but almost normal transport kinetics. 
The mutants, which lack domain I or III, respectively, are badly folded and not capable 
of leaving the ER. However, domain III alone is per se transport-competent, 
enzymatically active and efficiently sorted to the apical membrane in polarized cells, but 
can only be detected as monomeric forms. Altogether, the data strongly suggest a 
hierarchical model of the early folding events of nascent pro-LPH. Here, membrane 
associated domain IV has a regulatory role of in the trafficking of pro-LPH, while domain 
III constitutes the core domain of the whole protein, functions as a second 
intramolecular chaperone and comprises the information for apical sorting. 
 
Key words: Lactase phlorizin hydrolase, congenital lactase deficiency, folding, 
intramolecular organisation, trafficking, detergent resistant membranes. 
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1. Introduction      
 
The biological cell is the central unit within the self-organisation of an organism, the 
maintenance of its functions therefore is essential. One crucial presupposition is the 
supply of distinct subcellular compartments with specific proteins. The basis for 
correct protein trafficking and consequently the fulfillment of its biological role is the 
acquisition of a native conformation via correct folding. 
In virtue of the fact that misfolded polypeptides constitute the molecular basis of 
many inherited diseases, investigations on the mechanisms which contribute to and 
guarantee correct folding constitute a major and important part of current research. 
These mechanisms contain interactions between cellular protein components and 
structural elements within a polypeptide [Hammond and Helenius, 1994; Hutt et al., 
2009]. Therefore, insights into the intramolecular organisation of proteins are of great 
significance for the understanding of fundamental molecular and cell biological 
processes. That is why an extension of knowledge in this field is of use as a basis for 
diagnostic and therapeutic progress concerning disorders associated with this 
subject. 
 
 
1.1 Protein biosynthesis, folding, processing, and transport 
 
The achievement of the native conformation is the condition to be fulfilled that a 
protein can be transported to its target site and be functional. Therefore, correct 
folding is a prerequisite for its full functionality. 
Theoretically, a peptide with n amino acids could form 8n conformations, because in 
the peptide backbone stereochemically eight bond angles are possible; however, 
under cellular conditions only one is realized. In this most stable structure about 95% 
of all intracellular proteins are found [Lodish et al., 2004]. 
 
1.1.1 The secretory pathway 
Most of the proteins of a eucaryotic cell are encoded within the nucleus, but their 
biosynthesis occurs in two different ways. 
The mRNA of cytoplasmic, nuclear, mitochondrial, plastidal, and peroxisomal 
proteins is translated by free cytoplasmic ribosomes. After correct folding, the 
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polypeptides either remain in the cytoplasm or are transported to final destinations by 
means of their compartment-specific target and entry sequences. The proteins of the 
secretory pathway  – like proteins of the ER, the Golgi apparatus, the lysosomes, as 
well as secreted and integral membrane proteins [Griffiths and Simons, 1986; 
Palade, 1975] – are synthesized by cytoplasmic ribosomes bound to the membrane 
of the rough ER during translation. Fig. 1.1 gives an overview over the secretory 
pathway. 
 
 
 
 
B 
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Fig. 1.1: Conventional secretory pathway (A) and unconventional transport of 
signal-peptide-containing proteins (B). 1-4 indicate different routes and 
mechanisms of unconventional protein transport. (From [Nickel and Rabouille, 2009]) 
 
 
 
1.1.2 Translocation in the ER 
Signal sequences within a pre-pro-peptide precursor play a crucial role for the 
interaction between ribosomes and the ER. These sequences are predominantly 
localized N-terminally and are revealed and exposed co-translationally. The 
hydrophobic core within a signal sequence of a nascent polypeptide binds to a 
signal-recognition particle (SRP). This SRP directs the ribosome to an SRP-receptor 
in the ER membrane and interacts with it. Subsequently, the ribosome binds a 
translocase associated with the SRP-receptor [Gilmore, 1993; Johnson and van 
Waes, 1999]. In coordination with other ER-specific proteins, the nascent, unfolded 
polypeptide [Rapoport et al., 1996; Shaw et al., 1988] is translocated through the 
translocase channel into the ER lumen or it is inserted into the ER membrane, 
respectively. 
Integral membrane proteins can be inserted in the lipid bilayer in different ways. 
Either a covalent bound glycosyl-phosphatidylinositol (GPI)-anchor is attached 
[Brown et al., 1989; Englund, 1993; Lisanti et al., 1989; Lisanti and Rodriguez-
Boulan, 1990; Lisanti et al., 1988], or one or more transmembrane domains exist as 
topogenic amino acid sequences. 
Topogenic sequences are responsible for the co-translationally determined 
orientation of the protein in the membrane [Hartmann et al., 1989]. Type-II-
membrane proteins have a cytoplasmic N-terminus and a luminal or extra-cellular C-
terminus, respectively, which is translocated in the ER after completed biosynthesis 
[Shaw et al., 1988]. Type-I-membrane proteins have an N-terminal, cleavable signal 
sequence and a C-terminally following stop-transfer signal-anchor sequence. 
Therefore, the N-terminus is located in the lumen or extra-cellularly, respectively, and 
the C-terminus is in the cytoplasm. 
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1.1.3 Folding in the ER 
The ER is the secretory pathway site-of-entry for newly synthesized proteins. Its 
lumen constitutes a specialized folding environment with several molecular 
chaperones and folding factors and because of this enables rapid folding into a 
native structure [Gething and Sambrook, 1992]. Therefore, in this compartment the 
pre-conditions for the achievement of transport competence and oftentimes of 
biological functions of many secretory and integral membrane proteins are created 
[Gething and Sambrook, 1992; Hurtley and Helenius, 1989; Hutt et al., 2009; 
Kornfeld and Kornfeld, 1985; Rose and Doms, 1988; Wiseman et al., 2007]. 
 
Co- and post-translational modifications influence biological activity, lifespan as well 
as intra- and extra-cellular localization of proteins and are therefore of decisive 
importance. These processes can be differentiated in partly reversible chemical 
modifications and generally irreversible proteolytic alterations. 
Reversible reactions are e.g. acetylation of terminal regions, phosphorylation and de-
phosphorylation of serine, threonine and tyrosine residues as well as glycosylation of 
asparagines, serine and threonine residues. 
Protein processing contains irreversible removal of C- or N-terminal amino acid 
residues by proteases or by auto-proteolysis [Lodish et al., 2004]. Existing cleavable 
signal sequences are removed proteolytically during translation by a signal peptidase 
and subsequentially degraded [Dalbey and Von Heijne, 1992]. 
The formation of intramolecular – and possibly later intermolecular – disulfide bonds 
occurs co-translationally, too, in the context of the folding process [Gething, 1997]. 
Disulfide bonds oftentimes are necessary for stability, further maturation, intracellular 
transport and protein function. This kind of chemical bonds can only form within the 
non-reducing milieu of the ER lumen [Wilson et al., 1998] and can therefore only be 
found for secreted proteins and exo-plasmatic domains of membrane proteins. 
Additionally, the spontaneous formation of disulfide bonds during ongoing protein 
biosynthesis can afterwards be re-organised by protein-disulfide isomerase (PDI) to 
guarantee the correct pairing of the cysteine residues [Bulleid and Freedman, 1988; 
Wilson et al., 1998]. 
Such isomerisation reactions, and others like the rotation of peptidyle-prolyle bonds 
by peptide-prolyle isomerase (PPI), are in many cases the rate-limiting events during 
                                                                                                                   Introduction 
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protein domain folding. Generally, small domains are stabilized at first and distant 
regions later [Lodish et al., 2004]. 
 
The information for the achievement of the native conformation is determined within 
the amino acid sequence of a protein, therefore folding can be considered as an 
auto-regulated process. However, a high folding efficiency at given intra-cellular 
conditions is only facilitated by chaperones [Ellis and Hemmingsen, 1989; Gething 
and Sambrook, 1992]. Chaperones inhibit any impermissible intermolecular 
interaction [Ellis and van der Vies, 1991] and thus avoid aggregation of unfolded 
proteins, and their early folding and assembly, respectively. They support folding 
processes and are capable of binding misfolded proteins and to adjust the structure 
of the latter [Wilson et al., 1998]. 
Two families of chaperones can be distinguished: molecular chaperones and 
chaperonines. Molecular chaperones protect unfolded or only partly folded proteins 
from degradation by intracellular peptidases. Chaperonines display an ATPase 
activity and are directly involved in protein folding. Some of the eucaryotic proteins 
like actin or tubuline depend on the presence of chaperonines like TciPs during their 
folding process, whereas bacterial chaperonines like GroEL and GroES play a more 
important role [Lodish et al., 2004]. 
Molecular chaperones are part of the Hsp70 protein family. Characteristic 
representatives are Hsp70 (in the cytoplasm and the mitochondrial matrix), BiP, 
Hsc70 (in the ER), and DnaK (in prokaryotes). They are fundamentally important for 
the formation of a transport-competent conformation [Munro and Pelham, 1986; Ou 
et al., 1993].  
 
1.1.4 Glycosylation 
Protein glycosylation is initiated co-translationally by covalent attachment of sugar 
chains. Most of the secreted and plasma membrane proteins carry at least one 
carbohydrate chain. Glycosylation is the most important and most frequent 
modification of these polypeptides [Reuter and Gabius, 1999]. 
The attachment of sugar chains begins in the ER. Subsequently, glycans are 
modified stepwise in this compartment and the Golgi apparatus; hence, glycan status 
and structure indicates the intracellular region of glycosylation. Cytosolic and nuclear 
proteins usually are not glycosylated [Lodish et al., 2004]. 
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Co- and post-translational attachment and modification of carbohydrate side-chains 
can be differentiated in two types of glycosylation: O- and N-glycosylation, which both 
can be found together with different frequency for one polypeptide. 
 
O-glycosylation 
As to O-glycosylation [Roth, 1984], oligosaccharides are short and comprise at most 
four monosaccharides. Its transfer occurs stepwise and is catalyzed by glycosyl-
transferases, which are highly specific, integral membrane proteins. 
Monosaccharides contained in the glycans of glyco-proteins and -lipids originate from 
sugar residues of cytoplasmic nucleotide precursors. These precursors are build up 
in the cytoplasm from nucleoside-tri-phosphate and monosaccharide-phosphates and 
transported in the lumen of the appropriate cellular compartment via antiport [Lodish 
et al., 2004]. O-glycosylation is initiated by the binding of N-acetyl-α-D-galactosamine 
(GalNAc) to the hydroxyl group of a serine or threonine in the cis-Golgi. After the 
adding of one galactose (Gal) molecule within the trans-Golgi, more GalNAc and Gal 
molecules can bind to this core structure. Finally, sialic acid and L-fucose are added 
[Reuter and Gabius, 1999]. 
 
N-glycosylation 
As to N-glycosylation, a sugar residue is bound to an amino group of an asparagine 
residue over an N-acetyl-glucosamine (GlcNAc) molecule. Thereby, the asparagine  
has to be part of the consensus sequence Asn-X-Ser/Thr, with the X being any 
amino acid except proline [Kornfeld and Kornfeld, 1985; Reuter and Gabius, 1999]. 
The actual addition of carbohydrate residues can not happen at all potential 
glycosylation sites, because not all sites are sterically accessible. Generally, potential 
N-glycosylation sites are more accessible for unfolded proteins [Allen et al., 1995]. 
Oligosaccharides contain mannose (Man) and GlcNAc and branches with a terminal, 
negatively charged sialic acid residue. Additionally, glucose (Glc), Gal and fucose 
can be bound. These carbohydrates are added to the protein co-translationally as a 
complex of fourteen sugar molecules en block by an oligosaccharide protein 
transferase (OSPT). This OSPT is anchored in the ER membrane and transiently 
associated with the glyco-protein synthesizing ribosome generating a spatial vicinity 
to the nascent polypeptide [Lodish 2004]. Before its transfer to the protein, the sugar 
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complex is bound to dolichol – an unsaturated isoprenoide, incorporated in the ER 
membrane – via a pyro-phosphate residue as oligosaccharide precursor [Kornfeld 
and Kornfeld, 1985]. The composition of three Glc, nine Man and two GlcNAc 
molecules [Trombetta and Helenius, 1998] is identical for plants, animals, and 
eucaryotic protozoa; a core of two GlcNAc and three Man molecules constitutes the 
structural element of all N-glycosidically bound oligosaccharides [Lodish et al., 2004]. 
After the oligosaccharide transfer its processing begins with the removal of one Man 
and three Glc molecules [Kornfeld and Kornfeld, 1985]. If the glyco-protein has not 
yet achieved its native conformation at this moment or is it misfolded, a Glc residue is 
re-added by the UDP-glucose:glycoprotein-glycosyl-transferase [Ponnambalam and 
Banting, 1996]. The latter identifies specific protein regions, which have an incorrect 
structure and therefore functions as a folding sensor [Ritter and Helenius, 2000]. 
Absence of N-glycosylation results in ER retention for many proteins. Secreted 
proteins, however, rarely accumulate, but in general are structurally more instable 
outside of the cell [Lodish et al., 2004].  
 
Most of the glyco-proteins are transported to the Golgi apparatus as Man-rich protein 
forms by COP-II vesicles [Klumperman, 2000]. There, glycans are variously modified 
by different enzymes of the cis-, medial and trans-Golgi cisterns [Elbein, 1991; 
Kornfeld and Kornfeld, 1985]. By that, the diversity of complex glycosylated protein 
forms – typical for mammalian cells – is generated step by step. If one of these steps 
does not occur, the following ones are omitted, too [Elbein, 1991]. 
Each O- and N-glycosylation site typically possesses several glycan structures. 
Therefore, a glyco-protein constitutes a mixture of different glyco-forms with a varying 
number, localization, and sequence of glycans [Elbein, 1991]. Glycosylation 
influences folding, oligomerisation, transport, proteolytic degradation, and enzymatic 
activity [West, 1986]. Furthermore, glycans play an important role for protein-protein 
and protein-lectin interactions inter alia in the context of cell adhesion and cell 
migration [Zhao et al., 2008]. 
 
1.1.5 ER-to-Golgi-transport 
The ER – and probably the Golgi apparatus, too – comprises a quality control system 
that retains most un- or misfolded proteins as well as monomers of proteins with an 
oligomeric quaternary structure [Anelli and Sitia, 2008; Ellis and Hemmingsen, 1989; 
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Fagioli and Sitia, 2001; Fink, 1999; Hurtley and Helenius, 1989; Propsting et al., 
2005]. Proteins, which do not achieve their energetically most advantageous 
conformation, do not have to be restricted in their function. However, they are 
structurally more instable and therefore more susceptible for degradation in general. 
 
Protein folding is a multi-step process, which is regulated on different levels. Firstly, 
there is a general folding control mechanism, which is characterized by the fulfillment 
of a particular folding order with few intermediate forms. Secondly, a cellular system 
exists, in which e.g. an increasing number of unfolded polypeptides in the ER 
induces an increase of (compartment-specific) chaperone and folding catalyst 
expression like Hsc70, PPI, and PDI [Lodish et al., 2004]. Additionally, gene 
expression of proteosomal proteins seems to be transcriptionally regulated because 
its increase is induced by the accumulation of misfolded polypeptides [Kaufman, 
1999; Mori et al., 1992; Ng et al., 2000]. 
 
The majority of incorrectly folded proteins does not reach the Golgi apparatus and 
accumulates [Hurtley and Helenius, 1989], their detection possibly occurs because of 
membrane spanning regions [Lodish et al., 2004]. Moreover, there seems to be a 
quality control system at the Golgi apparatus level. It identifies misfolding indicating 
structures and retains the corresponding proteins [Doms et al., 1987; Hauri et al., 
1985a; Naim et al., 1988; Propsting et al., 2005]. Most of them are translocated in the 
cytoplasm [Brodsky and McCracken, 1999; Wiertz et al., 1996], deglycosylated, 
ubiquitinated, and degraded by the proteasome [Hershko and Ciechanover, 1998; 
Vembar and Brodsky, 2008]. Furthermore, a rapid, directed protein degradation can 
also be induced by proteolytic sequences localized within the polypeptide itself, like 
the PEST sequence (Pro-Glu-Ser-Thr) [Rechsteiner and Rogers, 1996]. Generally, 
protein degradation limits lifespan of all proteins. Fig. 1.2 summarizes glycosylation 
and degradation events. 
 
                                                                                                                   Introduction 
9 
 
Fig. 1.2: N-linked glycosylation and the degradation of glycosylated proteins. 
(Taken from [Vembar and Brodsky, 2008])  
 
Beside the selective retention and re-location of incorrectly folded proteins, these 
processes can be observed for several compartment-specific polypeptides, too. One 
of the underlying retention signals [Rothman and Wieland, 1996] is the C-terminally 
localized KDEL-peptide (Lys-Asp-Glu-Leu) [Munro and Pelham, 1987], which results 
in the retention of luminal ER proteins [Lodish et al., 2004]. Another signal is the also 
C-terminally localized di-lysine motif of membrane-anchored ER proteins, e.g. the 
KDEL-receptor. This motif together with COP-I vesicles directs the corresponding 
polypeptides from the Golgi apparatus back to the ER [Pelham, 1995]. 
 
1.1.6 Transport from the Golgi apparatus to the final destination 
Within the cisterns of the Golgi apparatus, more glycans can be added, present ones 
be modified, and further proteolytic events occur. The anterograde transport through 
this compartment occurs by the progression of cisterns. By that, cis-Golgi cisterns 
(including their contents) migrate to the trans-Golgi network (TGN) [Lodish et al., 
2004]. However, the cisternal maturation/progression model is not applicable for all 
cell types, e.g. for cells with a high secreting activity [Kartberg et al., 2005]. From the 
Golgi, the proteins which are not Golgi-resident are transported in vesicles to 
lysosomes, endosomes, or the plasma membrane, respectively, after sorting has 
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occurred [Griffiths and Simons, 1986]. Sorting itself depends on the interaction of 
distinct protein structures with specific receptors, i.e. cellular sorting machineries 
[Ikonen and Simons, 1998]. Particular secretory proteins are constitutively secreted, 
if no sorting signals exist, which could induce transport to certain intracellular regions. 
Other secretory proteins are concentrated and stored in secretory vesicles for 
regulated secretion in the form of exocytosis after a neuronal or hormonal signal. 
 
Moreover, concerning protein and lipid targeting in polarized epithelial cells, one has 
to differentiate between an apical and a basolateral membrane domain, which differ 
structurally as well as functionally [Rodriguez-Boulan and Powell, 1992; Simons and 
Wandinger-Ness, 1990]. Their spatial separation originates and is maintained by tight 
junctions. These cell-cell-connections prevent the flow of extracellular liquid through 
the epithelium as well as protein and lipid diffusion between both plasma membrane 
domains. These domains possess different protein and lipid compositions because of 
directed supply [Egan et al., 2004; Massey-Harroche, 2000; Mostov et al., 2000; 
Simons and Wandinger-Ness, 1990; van Meer and Simons, 1986]. The generation 
and the maintenance of this asymmetry are fundamentally important for the 
physiological processes in polarized cells, e.g. signal transduction, absorption, and 
secretion. 
During transport, basolateral and apical proteins are at first localized in the same 
TGN vesicles. However, they are found to be in different transport vesicles 
afterwards [Keller et al., 2001]. Thereby, signals within the transported proteins 
induce their segregation into different carrierss. Particular proteins on the surface of 
these vesicles – e.g. Rab [Chavrier et al., 1990] and v-SNARE proteins [Lodish et al., 
2004] – are crucial for correct transport to one or the other membrane domain and 
induce membrane fusion. 
 
A variety of intramolecular sorting signals could be found, which are identified by 
cellular components and carry the information for a directed transport [Casanova et 
al., 1991a; Casanova et al., 1991b; Delacour and Jacob, 2006; Hunziker et al., 1991]. 
Basolateral sorting signals appear in cytoplasmic domains of basolateral proteins 
[Brewer and Roth, 1991; Casanova et al., 1991a; Hunziker et al., 1991], e.g. as short 
amino acid sequences like the di-leucine [Hunziker and Fumey, 1994] and tyrosine 
motif [Brewer and Roth, 1991]. Basolateral proteins which lack the cytoplasmic 
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domain normally are sorted apically, wherefore apical sorting signals are likely 
localized in the transmembrane or ectodomain. Here, – and generally in protein 
sorting – N- and O-glycans could play a crucial role [Alfalah et al., 1999; Fiedler and 
Simons, 1995; Krahn et al., 2010; Naim et al., 1999; Scheiffele et al., 1995; Yeaman 
et al., 1997]. However, basolateral sorting signals are not dominant on apical signals 
on principle [Jacob et al., 1999]. 
 
The ER-to-Golgi transport kinetics varies between proteins. The reason for this could 
be the different development of folding and oligomerisation processes [Gething and 
Sambrook, 1992; Hurtley and Helenius, 1989]. The transport from the Golgi 
apparatus to the cell surface develops asynchronously in comparison to the ER-to-
Golgi transport because of the modification within the Golgi apparatus [Jascur et al., 
1991]. 
 
1.1.7 Lipid rafts and detergent resistant membranes   
The association of several apically transported proteins with membrane 
microdomains, detergent resistant membranes (DRMs) or rafts [Simons et al., 1997] 
influences the transport mechanism [Jacob and Naim, 2001; Lindner and Naim, 
2009; Pralle et al., 2000; Simons and Fuller, 1985; Simons and van Meer, 1988] for 
several transmembrane proteins [Krahn et al., 2010; Lin et al., 1998] and GPI-
anchored proteins [Harder and Simons, 1997] as well. For other apically transported 
membrane proteins no relationship between sorting and the association with 
membrane microdomains could be demonstrated. Therefore, a raft-dependent and a 
raft-independent transport mechanism exist [Danielsen, 1995; Roper et al., 2000; 
Weisz and Rodriguez-Boulan, 2009; Yeaman et al., 1997; Zheng et al., 1999] 
indicating the existence of sorting signals within proteins. 
 
Lipid rafts are central accumulations of cholesterol and glyco-sphingolipids in plasma 
membranes, characterized by a reduced flow capability in comparison to the 
surrounding lipids. They constitute microdomains of the liquid-ordered (lo) phase in 
biological membranes [Simons and Ikonen, 2000]. They have been investigated by 
the isolation of DRMs of the liquid-ordered phase. New insights into the formation of 
lipid rafts show that they are not the same as DRMs [Lindner and Naim, 2009]. 
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The liquid-ordered phase is a sterol-dependent state, in which the lipid-acyl-chains 
are tightly packed and extended and lateral diffusion of single lipid molecules occurs 
[Veatch and Keller, 2005]. It is supposed that membrane domains of the ordered 
phase form also in sterol-rich membranes like plasma membranes resulting in a co-
existence of the ordered and the dis-ordered phase (ld) [Lagerholm et al., 2005]. 
However, the rafts hypothesis results from the discovery that glyco-sphingolipids 
accumulate in the Golgi apparatus already before they are transported to the apical 
membrane of polarized epithelial cells [Simons and van Meer, 1988]. Fig. 1.3 
illustrates the spatial lipid-lipid and lipid-protein associations found in rafts. 
 
 
Fig. 1.3: Model of a raft with two intercalated proteins. The liquid-ordered phase 
is shown in red and the liquid-disordered phase in blue. (From [Simons and Ikonen, 
2000]). 
 
An early sign of the cellular existence of rafts was the observation that cellular 
membranes are not completely soluble in non-ionic detergents like Triton X-100 or 
CHAPS. Therefore, the unsoluble DRMs of the liquid-ordered phase remained, which 
were rich in cholesterol and GPI-anchored proteins and could be isolated by 
saccharose gradients [Brown and Rose, 1992]. The DRMs achieved a high density 
because of the interaction of cholesterol with the carbohydrate chains of the 
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sphingolipids, facilitated by stabilizing hydrogen bonds [Simons and Ikonen, 2000]. 
This high lipid density in the liquid-ordered phase inhibits the penetration of 
detergents in the lipid bilayer [Xu et al., 2001]. DRM isolation results in the 
concentration of mainly plasma membrane proteins. Enrichment of DRMs shows that 
these proteins were concentrated in lipid rafts and that raft targeting has great 
importance. In spite of all do the isolated DRMs not correspond to lipid rafts in living 
cells, inter alia because DRM isolation with Triton X-100 occurs at low temperatures 
[Melkonian et al., 1995]. 
 
 
1.2 Intramolecular protein organisation 
 
1.2.1 Protein domains 
Most of the secreted and some plasma membrane proteins are synthesized as pre-
pro-forms. These are modified proteolytically on their way from the TGN to the cell 
surface leading to mature or active protein forms, respectively [Barr, 1991; Robakis 
et al., 2008; Steiner et al., 1984]. Here, irreversible removal of N-terminally localized 
pro-peptides plays an important role [Barr, 1991; Steiner et al., 1984]. 
 
These pro-peptides consist – like the rest of the protein – of one or more structural 
domains of the tertiary structure. These domains can be compact globule modules or 
linking domains [Brunger, 2001]. Moreover, they can appear as clearly outlined 
regions with distinct boundaries, which border on flanking areas like membrane 
regions or long domain-separating coiled-coiled helices [Abrahams et al., 1994]. 
Structural domains contain one- to three-hundred amino acid residues [Gething, 
1997] and comprise various combinations of α-helices, β-sheets, hairpin structures 
and random balls. The frequency of the appearance of a particular amino acid in a 
particular protein region oftentimes is a special structural characteristic [Lodish et al., 
2004]. Frequently, protein domains contain specific conserved sequences and 
secondary structure motifs like zinkfingers or loops. They constitute semi-
independent three-dimensional units within proteins, which are capable to fold 
independently [Gething, 1997; Jaenicke, 1987] – and in eukaryotes also sequentially 
during translation [Bergman and Kuehl, 1979; Braakman et al., 1992; Gething, 1997; 
Kolb et al., 1994; Peters and Davidson, 1982].  
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Protein domains oftentimes are associated with specific functions, whereby a distinct 
area – e.g. a catalytic or binding domain – is related to the biological function of a 
protein. Such a functional domain can comprise several structural domains. This 
functional definition of a domain is less strict as the structural definition, but is of 
particular relevance, when the three-dimensional structure is unknown [Lodish et al., 
2004]. 
The subdivision of the whole tertiary structure in structural domains corresponds to 
the principle, that complex molecules are comprised of simple elements. In different 
proteins recombination [Teichmann et al., 2001] of similar domains can occur by 
gene fusion or exon shuffling [Gething, 1997]. Homologous proteins display an amino 
acid sequence similarity of the whole length and usually a similar function. These 
sequence similarities mostly result from evolutionary relationship and indicate one 
ancestor, wherefore homologous proteins can be classified in families together. In 
the context of rapid evolution of eucaryotic multi-domain proteins facilitated by the 
development of complex genes [Gething, 1997], domains could constitute units of 
evolution [Holm and Sander, 1994]. 
 
The knowledge of the exact boundaries of structural domains is especially important 
as well as for the determination of the three-dimensional structure [Gething, 1997] as 
for the functional characterization of protein regions. The prediction of a three-
dimensional structure (biomodeling) occurs on the basis of the amino acid sequence 
under the consideration of the frequency probability of single amino acids in distinct 
secondary structures [Lodish et al., 2004]. 
 
1.2.2 Intramolecular chaperones 
For a particular region of some proteins a function as intramolecular chaperone is 
postulated [Chen and Inouye, 2008], whereby specific domains support or regulate 
the folding process of other domains [Naim et al., 1994; Oberholzer et al., 1993; 
Sagherian et al., 1994]. The region, which functions as intramolecular chaperone can 
be part of the mature protein like for sucrase-isomaltase [Jacob et al., 2002b]. 
However, for the majority of the proteins with identified intramolecular chaperone a 
cleavable pro-peptide carries this function, e.g. for subtilisin [Barr, 1991; Zhu et al., 
1989], the bovine pancreatic trypsin inhibitor [Weissman and Kim, 1992], activin A 
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and TGF-β-1 [Gray and Mason, 1990], cathepsin C [Cigic et al., 2000], type-1-matrix-
metalloproteinase [Cao et al., 2000], and lactase phlorizin hydrolase [Jacob et al., 
2002a]. The pro-regions of these proteins are localized N-terminally, probably to 
facilitate an early participation in the folding process of the remaining protein part. 
However, C-terminally located intramolecular chaperones could be identified in 
mammalian [Jacob et al., 2002b] and non-mammalian cells [Conesa et al., 2001; 
Feller et al., 1998; Muhlenhoff et al., 2003]. 
 
 
1.3 Lactase phlorizin hydrolase 
 
Intestinal lactase phlorizin hydrolase (LPH; EC 3.2.1.62/108) is a physiologically 
important digestive enzyme in the mammalian small intestine. It belongs to the group 
of brush border membrane hydrolases, which include disaccharidases and 
peptidases [Buller et al., 1987; Danielsen et al., 1984; Mantei et al., 1988; Naim, 
1987]. 
 
1.3.1 Physiology and pathophysiology  
Based upon its site-of-function and its disaccharidase activity, LPH together with 
sucrase-isomaltase, maltase-glucoamylase [Naim, 1987], and trehalase builds the 
more narrow group of intestinal disaccharidases. LPH is a membrane-bound β-
glycosidase with two physically similar family-1-glycosyl hydrolase-domains  
[Colombo et al., 1973; Naim, 2001; Schlegel-Haueter et al., 1972; Skovbjerg et al., 
1981] localized on one polypeptide chain [Mantei et al., 1988] and comprises two 
enzymatic activities, lactase and phlorizin hydrolase activity.  
Phlorizin hydrolase (PH; glycosyl-N-acylsphingosine gluco-hydrolase) [Colombo et 
al., 1973; Kraml et al., 1972; Schlegel-Haueter et al., 1972; Skovbjerg et al., 1981] is 
a β-glycosyl-ceramidase with a broad specificity. The substrate range contains 
amongst others vertebrate alimentary β-glycosyl-ceramides [Leese and Semenza, 
1973], some aryl-β-glycosides like phlorizin  [Leese and Semenza, 1973; Zecca et 
al., 1998] as well as flavonoid-glycosides [Day et al., 2000]. The exact physiological 
role of PH still needs to be determined [Naim, 2001].  
Most of the disaccharides found in the food of mammals consist of α-glycosidic linked 
monosaccharides, but one example of β-linked monosaccharides is lactose, which is 
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the most important carbohydrate in milk. The portion of lactose in human breast milk 
is about 7% and therefore higher than in other mammals. All mammals produce milk, 
which is therefore the main nutrient for newborns. The most important physiological 
task of LPH is therefore the cleavage of lactose with its lactase activity, which has 
lactose as its specific substrate [Zecca et al., 1998]. This disaccharide is hydrolysed 
in the lumen of the small intestine to galactose and glucose [Colombo et al., 1973]. 
Absorption of monosaccharides occurs via the microvilli of the brush border 
membrane by means of a galactose-specific, membrane-bound, and energy-
dependent glucose/galactose transporter. 
Lactose can not be uptaken by the enterocytes as an uncleaved molecule. However, 
the limiting factor of lactose digestion is not monosaccharide uptake, but hydrolysis of   
lactose by lactase. In contrast to other disaccharidases, lactase has a distinctly lower 
enzymatic activity [Henning, 1981]. A further, pathological decrease or an complete 
absence of lactase activity leads to osmotic diarrhoea with accompanying symptoms 
after ingestion of lactose containing food [Buller and Grand, 1990; Phillips et al., 
1978]. This is the case for adult type hypolactasia concerning many mammals [Doell 
and Kretchmer, 1962; Henning, 1981]. However, the majority of human grown-ups 
are confronted with this widespread intestinal disorder also. Here, lactase activity 
declines rapidly and drastically after suckling period during early childhood or youth, 
respectively [Lebenthal et al., 1975]. This results in a substantially limited range of 
foods [Harvey et al., 1995; Wang et al., 1995]. Not afflicted are Northern Europeans, 
their descendants, and isolated groups in Africa and Asia, because lactase activity 
does not decrease and stays at high levels all one’s lifetime [Harvey et al., 1995; 
Wang et al., 1995]. 
This phenomenon is determined genetically, with an autosomal-dominant allele being 
the cause for lactase persistence and an autosomal-recessive variant of the same 
gene locus causing adult-type hypolactasia [Sahi et al., 1973]. However, ethnic and 
geographic variations of lactose malabsorption exist, e.g. the different rate of lactase 
persistence between North- and South-India is connected to the -13910C/T 
polymorphism [Babu et al., 2010], which constitutes the first discovered variant 
correlated to lactase intolerance [Enattah et al., 2002]. Moreover, other single-
nucleotide polymorphisms of the lactase gene are also linked to lactase persistence, 
whereby the alleles can be found in different pastoral populations. The -13910C/T 
polymorphism, for example, is not significantly correlated to lactase persistence in a 
                                                                                                                   Introduction 
17 
Chinese population, whereas the -22018A allele is [Xu et al., 2010]. Meanwhile, a 
database has been build up, which includes the worldwide distribution of lactase 
persistence and its correlation to the -13910T allele [Ingram et al., 2009a]. 
Interestingly, the European -13910T variant and the East-African -13907G allele, 
both associated with lactase persistence, were found to share the identical ancestral 
background – and probably history – because of the same cattle domestication event 
[Enattah et al., 2008]. A recently identified lactase persistence allele found in Arab 
populations has a different and divergent ancestral haplotype, suggesting that this 
variant developed independently, probably because of beginning camel milk 
consumption [Enattah et al., 2008].  
The convergent lactase persistence evolution in different populations most likely 
reflects the historical diversity of milk drinking culture adaption. Furthermore, several 
lactase persistent individuals could be identified, who do not have the allele 
supposed to be associated with lactase persistence, but other (rare) single-
nucleotide polymorphisms in the same genome region. For example, within a group 
of Somali camel-herds in Ethiopia eight new polymorphic sites were found including 
two significantly connected to lactase persistence [Ingram et al., 2009b]. However, a 
significant correlation between the hypolactasia genotype -13910C/C of a cohort of 
young Russians in North-West-Russia and the consumption of milk and milk-
containing formula could not be detected [Khabarova et al., 2009]. Additionally, the T 
allele of the -13910C/T polymorphism seems to be associated with the body mass 
index and increased prevalence of obesity [Kettunen et al., 2010], whereas -
13910C/C individuals are supposed to drink less milk and have a reduced calcium 
uptake [Laaksonen et al., 2009]. Besides, a correlation of milk consumption and 
lumbar bone mineral content as well as bone mineral density could also be detected 
[Esterle et al., 2009]. Very recently, another mechanism of lactase regulation was 
proposed. Here, the RNA-binding protein ‘quaking’ regulates differentiation of colon 
epithelia, acts as tumor suppressor and increases lactase expression after forced 
expression of ‘quaking’ [Yang et al., 2010].  
Further analyses of the molecular mechanisms and the forces driving evolution are 
necessary to understand lactase regulation completely. The latter constitutes a 
valuable model to elucidate gene-culture co-evolution as well as susceptibility 
towards diseases. Moreover does it show the limits of single-nucleotide tagging and 
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clarifies the potential and the importance of distant regulator elements [Ingram et al., 
2009a].  
 
1.3.2 Biosynthesis 
Biosynthesis of LPH in humans is representative for other investigated species 
[Buller et al., 1987; Danielsen et al., 1984; Naim, 1987]. LPH is synthesized as a 
single-chain precursor molecule. This pre-pro-LPH comprises an N-terminal 
cleavable signal peptide (Met1-Gly19), four homologous domains (Ser20-Thr1882), and 
a membrane-anchoring region (Ala1883-Leu1901), which crosses the lipid bilayer of the 
cellular membranes in a helical conformation and fixes the protein at the membrane. 
Moreover, a cytoplasmatic domain can be found at the C-terminal end (Ser1902-
Phe1927) [Mantei et al., 1988]. 
 
 
Fig. 1.4: Structural features of human pre-pro-LPH. 
 
 
The existence of four homologous, highly conserved domains and in particular the 
similarity of the profragment with the region containing domains III and IV suggest 
that LPH has evolved from two partially gene duplications of one ancestral gene 
[Mantei et al., 1988]. Additionally, each of the homologous domains shares 
similarities in size with prokaryotic β-glycosidases as well as sequence similarities 
with β-glycosidases of archaea, eubacteria and fungi. Therefore, LPH likely is a 
member of a super family of β-glucosidases and β-galactosidases [Mantei et al., 
1988; Naim, 2001]. 
The gene locus of human LPH is found on chromosome 2 [Kruse et al., 1988] and 
contains 17 exons within approximately 55kb [Boll et al., 1991]. The cDNA comprises 
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6274 bp [Boll et al., 1991; Kruse et al., 1988; Mantei et al., 1988] and pre-pro-LPH as 
primary product of translation is composed of 1927 amino acids [Mantei et al., 1988]. 
 
The signal peptide of LPH is essential for translocation into the ER [von Heijne, 1986] 
and is removed cotranslationally at the amino acid residues Gly19/Ser20 within the ER 
lumen [Mantei et al., 1988; von Heijne, 1986]. The resulting pro-LPH is fixed in the 
ER membrane via its C-terminal membrane-anchoring domain. Because of its Cin-
Nout-orientation, LPH is a type-I membrane protein [Blobel, 1980]. During the 
achievement of a correctly folded transport-competent conformation, highly 
mannose-rich glycosylation occurs (-> pro-LPHh; 215 kDa), whereas 15 potential N-
glycosylation sites exist within the molecule [Naim, 1992; Naim and Naim, 1996; 
Zecca et al., 1998]. Furthermore, a correctly folded transport-competent conformation 
is a precondition of the assembly of two subunits into one homodimer [Naim and 
Naim, 1996; Sterchi et al., 1990]. 
The molecular chaperone BiP has a stabilizing effect on unfolded or partially folded 
proteins [Gething and Sambrook, 1992] and is involved in the pro-LPH folding 
process in the ER [Jacob et al., 1995]. The C-terminally located membrane-anchor 
plays an important role for pro-LPH dimerisation, and dimerisation itself is essential 
for the protein in order to leave the ER and to acquire enzymatic activity [Naim and 
Naim, 1996].  
 
Within the Golgi apparatus, complex N-glycosylation occurs in consequence of the 
final processing of the N-glycans [Hauri et al., 1985b; Naim et al., 1991]. Also, O-
glycosylation of the complex is taking place [Hauri et al., 1985b; Naim, 1992; Naim et 
al., 1991; Naim, 1987], resulting in a four-fold increase of LPH enzymatic activity (-> 
pro-LPHc, 230kDa) [Naim and Lentze, 1992]. 
After that, the propeptide Ser20-Arg734 (LPHα) including complete homologous 
domain I and more than two thirds of domain II is removed in the trans-Golgi network 
[Jacob et al., 1994; Naim, 1992]. This occurs during a second proteolytic cleavage 
step [Danielsen et al., 1984] with a trypsin-like protease [Hauri et al., 1985b; Naim, 
1987; Skovbjerg et al., 1984] at Arg734 /Leu735 (-> LPHβinitial, 160kDa) [Jacob et al., 
1996; Wuthrich et al., 1996; Yeh et al., 1991]. Probably, LPHα is degraded 
subsequently [Naim et al., 1994; Ouwendijk et al., 1998]. 
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Finally, the protein is transported in vesicles from the trans-Golgi network to the 
apical surface of the enterocytes where the mature form of the polypeptide (-> 
LPHβfinal, 145kDa) can display its physiological function. LPHβfinal is generated by 
cleavage of luminal pancreatic trypsin within the small intestine at Arg868/Ala869 
[Jacob et al., 1996; Wuthrich et al., 1996]. The cleavage sites are indicated in Fig. 
1.4. 
The sorting signals are independent of glycosylation [Buller et al., 1989; Naim, 1994; 
Panzer et al., 1998] and the association with Triton X-100 resistant membrane 
microdomains [Alfalah et al., 1999; Danielsen, 1995; Jacob et al., 1999; Naim, 1994]  
but are presumably located in particular subdomains in the ectodomain [Jacob et al., 
1994; Jacob et al., 1999; Jacob et al., 1997; Panzer et al., 1998] or the 
transmembrane region [Jacob et al., 1999]. 
 
The brush-border LPH consists of homologous domains III and IV, the 
transmembrane region and the cytoplasmic tail and exerts its enzymatic functions as 
phlorizin-hydrolase, assigned to Glu1273 in domain III, and as lactase, assigned to 
Glu1749 in domain IV [Arribas et al., 2000; Zecca et al., 1998]. Nevertheless, the 
cleavage steps occurring in the Golgi apparatus of intestinal cells and in the small  
intestinal lumen are not required to generate a transport-competent [Naim et al., 
1991], a correctly sorted [Grunberg et al., 1992; Jacob et al., 1994; Jacob et al., 
1996] and an enzymatically active molecule [Naim et al., 1991]. 
The expression pattern of LPH on the mRNA and on the protein level is similar during 
development. The protein itself and the glycosylation pattern do not differ between 
LPH persistence and hypolactasia. Therefore, glycosylation  seems not to be 
weightily important for the regulation of LPH expression [Naim, 1987]. However, post-
translational mechanisms modify the final gene product, although the main 
mechanism of LPH regulation is transcriptional [Troelsen, 2005; Troelsen et al., 
1994a; Troelsen et al., 1994b]. LPH is hardly expressed in the crypts, the maximal 
expression occurs between the low and middle villus and decreases towards the 
villus top [Buller et al., 1989; Hauri et al., 1985b]. 
 
The cytoplasmic region contains an endocytic signal in close vicinity of the 
membrane, which is suppressed by the strong apical sorting signal localized in the 
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ectodomain or the transmembrane domain. Therefore, this signal is hardly accessible 
for interactions with chlathrin coated pits [Naim, 1992]. 
  
1.3.3 Intramolecular organisation 
The proportion of the complete pro-fragment Ser20-Arg868 from pre-pro-LPH is about 
45% and therefore is a sign of an important role of LPHα and the polypeptide stretch 
Leu735-Arg868. The significant homology with LPHβfinal led to the suggestion that the 
pro-fragment might have a glucosidase function in another cellular compartment 
[Mantei et al., 1988]. However, this was refuted by showing that pro-LPH and 
LPHβfinal have identical enzymatic activities [Naim et al., 1991], and by identifying the 
enzymatic centers [Zecca et al., 1998].  
 
LPHα is devoid of sorting signals [Grunberg et al., 1992; Jacob et al., 1994; Mantei et 
al., 1988] and catalytic activity [Zecca et al., 1998], neither complex N- nor O-
glycosylated [Naim et al., 1994] but rich in cysteine and hydrophobic amino acid 
residues suggesting a rapid folding to a compact globular domain [Jacob et al., 
2002a].  
Individual expression of LPHα [Jacob et al., 2002a] and LPHβfinal [Naim et al., 1994; 
Oberholzer et al., 1993] in COS-1 cells leads to localization of both polypeptides in 
the ER. Here, LPHα shows compact structural features stabilized by disulfide bonds 
[Jacob et al., 2002a], whereas LPHβfinal is identified predominantly as mannose-rich 
glycosylated protein form [Naim et al., 1994] with no measurable enzymatic activity 
[Jacob et al., 2002a]. 
Co-expression of LPHα and LPHβinitial results in the mature, trypsin-resistant, 
correctly folded, enzymatically active, and transport-competent LPHβinitial [Jacob et 
al., 2002a]. Individual expression of LPHβinitial, including the polypeptide stretch 
Leu735/Arg868 of homologous domain II, results in a temperature-sensitive and 
correctly sorted protein. It folds properly at 20°C, interacts with BiP [Jacob et al., 
2002a] in the ER, and is stable, trypsin-resistant, and enzymatically active. However, 
at 37°C it resides predominantly in the ER [Jacob et al., 2002a; Naim et al., 1994] as 
trypsin-sensitive and enzymatically inactive protein. During its biosynthesis at 37°C, 
LPHβinitial interacts sequentially with BiP and calnexin [Jacob et al., 2002a]. A small 
proportion reaches the Golgi apparatus and gets complex glycosylated. However, it 
is enzymatically inactive and trypsin-sensitive, because folding and N-glycosylation 
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pattern – especially considering the sialic acid residues – are different [Jacob et al., 
2002a]. 
 
These data show that LPHα indeed has the proposed intramolecular chaperone 
function [Mantei et al., 1988; Naim et al., 1994; Oberholzer et al., 1993] in enabling 
the correct folding of LPHβinitial during pro-LPH biosynthesis [Jacob et al., 2002a]. 
Furthermore, LPHα is expected to facilitate the formation or disulfide bonds like other 
profragments [Jacob et al., 1995] and to bind LPHβinitial directly. Its tendency to 
rapidly form a trypsin-resistant, enzymatically inactive core structure as folding 
template for the homologous domain LPHβinitial is LPH-specific and this intramolecular 
chaperone function can not be compensated by calnexin [Jacob et al., 2002a]. 
The data suggest that the stretch (Leu735/Arg868) together with LPHα plays an 
important role in the correct folding of the pro-LPH. 
 
 
1.4 Aim of the study   
 
Especially β-galactosidase, or lactase, has important applications in medicine, food 
technology and the environmental sciences. But preparation, for instance from the 
yeast Kluyveromyces lactis, is ineffective and therefore expensive due to the low 
stability and intracellular nature of the enzyme [Adam et al., 2004; Becerra et al., 
2004; Kim et al., 2004; Tahoun et al., 2002]. Consequently, inquiries on the structure-
function relationship of this and other homologous enzymes have economic 
relevance. 
 
The catalytic sites of the LPH are localized in homologous domains III and IV [Arribas 
et al., 2000; Zecca et al., 1998]. This has raised the question if these domains 
behave as autonomous regions and attain their enzymatically active conformation 
independently of each other in the context of the folding of the pro-LPH. And, 
supposing that these domains are indeed autonomous ones, one would ask if the 
possibility does exist to generate LPH mutants comprising more than two 
enzymatically active regions facilitating an increase of enzymatic activity.  
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Furthermore, the question which of the homologous domains, I or II, is more 
important, concerning the function of the removed polypeptide Ser20/Arg868 as an 
intramolecular chaperone, remained until present unanswered. 
 
LPH three-dimensional structure has not been worked out so far. A further 
characterisation of this protein with biochemical and cell biological procedures is 
necessary to achieve this goal and is a step in this direction. One aim of this study 
therefore was to investigate the influence of each of the four homologous domains on 
the structural and functional features of pro-LPH by directed change of domain 
composition. Moreover, the pathobiochemical and pathophysiological contexts of 
CLD have to be further investigated. In general, monogenetic diseases represent 
appropriate model systems to elucidate molecular, biochemical, cellular and 
physiological mechanisms and their analyses help to accelerate the development of 
individual diagnostic and therapeutic strategies. 
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2.  Materials and methods  
 
2.1  Materials    
 
2.1.1  Chemical reagents  
Acetic acid      Carl Roth GmbH (Karlsruhe, GE) 
Acrylamide Rotiphorese Gel30   Carl Roth GmbH (Karlsruhe, GE) 
Agarose, electrophoresis grade    Sigma Chem. Co. (Deisenhofen, GE) 
Ammonium peroxydisulfate (APS)   Carl Roth GmbH (Karlsruhe, GE) 
Ampicillin (D[-]-α-Aminobenzyle penicillin) Sigma Chem. Co. (Deisenhofen, GE) 
Bacto Agar       Carl Roth GmbH (Karlsruhe, GE) 
Bacto-Trypton      Carl Roth GmbH (Karlsruhe, GE)  
Bacto yeast extract     Carl Roth GmbH (Karlsruhe, GE)  
Bromphenole blue     Merck (Darmstadt, GE) 
Coomassie Brilliant Blue     Merck (Darmstadt, GE) 
Dimethyle sulfoxide (DMSO)    Carl Roth GmbH (Karlsruhe, GE) 
Dodecyl-β-m-maltoside     Sigma Chem. Co. (Deisenhofen, GE) 
Ethanol       Carl Roth GmbH (Karlsruhe, GE) 
Ethylenediaminetetraacetate (EDTA)   Serva Electrophoresis GmbH 
       (Heidelberg, GE) 
Fetal calf serum (FCS)    BioWest (Essen, GE) 
Glycerol       Carl Roth GmbH (Karlsruhe, GE) 
Isopropanol      Carl Roth GmbH (Karlsruhe, GE) 
Kanamycin       Sigma Chem. Co. (Deisenhofen, GE) 
Lactose       Sigma Chem. Co. (Deisenhofen, GE)  
Lubrol       MP Biomedicals GmbH (Eschwege, GE) 
L-[
35
S]methionine (>1000 Ci/mmol)  Amersham Biosci. Inc. (Freiburg, GE)  
N,N,N’,N’-tetramethylethylendiamine   Carl Roth GmbH (Karlsruhe, GE)   
  (TEMED)        
Phenol      Carl Roth GmbH (Karlsruhe, GE) 
Phlorizin       Sigma Chem. Co. (Deisenhofen, GE) 
Protein A-sepharose (PAS)    Amersham Biosci. Inc. (Freiburg, GE) 
Saponine      Sigma Chem. Co. (Deisenhofen, GE)  
Sodium deoxycholate    Carl Roth GmbH (Karlsruhe, GE) 
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Sodium dodecyl sulfate (SDS)    Carl Roth GmbH (Karlsruhe, GE) 
Sucrose      Carl Roth GmbH (Karlsruhe, GE) 
Trypsin inhibitor (from soya beans)   Sigma Chem. Co. (Deisenhofen, GE) 
Tris-hydroxymethyl-aminomethane (Tris)  Carl Roth GmbH (Karlsruhe, GE) 
Triton X-100       Sigma Chem. Co. (Deisenhofen, GE) 
Tween 20       Carl Roth GmbH (Karlsruhe, GE) 
 
All other reagents were of superior analytical grade. 
 
2.1.2  Enzymes 
Endo-β-N-acetylglucosaminidase H (Endo H) Roche Diagnostics (Mannheim, GE) 
Endo-β-N-acetylglucosaminidase F (Endo F) Roche Diagnostics (Mannheim, GE) 
Isis™ DNA-polymerase (and buffer)  Qbiogene (Heidelberg, GE) 
Restriction enzymes (and buffers)  MBI Fermentas (St. Leon-Rot, GE) 
RNAse A (from bovine pancreas)   Roche Diagnostics (Mannheim, GE) 
10 mg/ml stock solution  
T4 ligase      MBI Fermentas (St. Leon-Rot, GE) 
Trypsin       Sigma Chem. Co. (Deisenhofen, GE) 
Typ II-S from porcine pancreas    
    ca. 1800 BAEE units per mg solid 
  
2.1.3  Antibodies  
Monoclonal antibodies (mAbs) against human intestinal LPH were HBB 1/909 [Hauri 
et al., 1985b] and the MLac 1 to 10 [Maiuri et al., 1991]. The polyclonal antibody 
V496 is directed against the N-terminal part of the LPH prodomain [Naim et al., 
1994]. Anti-GFP antibodies were purchased from Invitrogen (Karlsruhe, GE). Anti-
FLAG andibodies were obtained from Sigma Chem. Co. (Deisenhofen, GE). 
 
2.1.4  Media, solutions, and buffers 
Media 
LB-Medium:    1% w/v NaCl  
1% w/v Bacto-Trypton  
0.5% w/v Bacto yeast extract  
autoclaved  
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LB solid medium:   LB-Medium + 1.5% w/v Bacto-Agar 
LB selection medium:   LB-Medium  
+30-50 mg/l Kanamycin or 
+50-100 mg/l Ampicillin  
 
DMEM (Dulbecco’s Modified Eagle Medium) Low Glucose (1 g/l ( D-)glucose) 
BioWest (Essen, GE) 
Culture medium:   DMEM  
+ 10% v/v FCS  
+ 1% v/v PSG  
MEM (Minimum Essential Medium) (w/o methionine) BioWest (Essen, GE) 
Starving medium   MEM + 1% v/v PSG  
Transfection medium:  DMEM+ 1% v/v PSG  
Hepes culture medium:  DMEM  
+ 10 mM Hepes  
 
Solutions 
ATP     Sigma Chem. Co. (Deisenhofen, GE) 
Benzyl-GalNAc   Sigma Chem. Co. (Deisenhofen, GE) 
Chloroquine:    Sigma Chem. Co. (Deisenhofen, GE) 
50 mg/ml, sterile filtered 
storage at –20 °C away from light 
Coloring solution:    0.1% w/v Coomassie Brilliant Blue  
  (for SDS-PAGE)   25% v/v isopropanol  
10% v/v acetic acid  
DEAE-dextran:    Amersham Biosci. Inc. (Freiburg, GE) 
  (Diethyle aminoethyle dextran) 50 mg/ml  
Discoloring solution:   25% v/v isopropanol  
  (for SDS-PAGE)   10% v/v acetic acid  
(1,4-)Dithiothreitol (DTT)   Carl Roth GmbH (Karlsruhe, GE) 
     1 M (for SDS-PAGE) 
     0.2 M (for ligation) 
dNTPs      MBI Fermentas (St. Leon-Rot, GE) 
  (Desoxynucleoside triphosphate) 25 mM dATP,dCTP,dGTP,dTTP 
                                                                                                 Materials and Methods 
27 
Ethidium bromide   Merck (Darmstadt, GE) 
10 µg/µl  
G418      Carl Roth GmbH (Karlsruhe, GE) 
Hepes :    Carl Roth GmbH (Karlsruhe, GE) 
  (N-2-Hydroxyethyle)piperazine-N-2-ethan-sulphonic acid) 1 M  
Monensin    Sigma Chem. Co. (Deisenhofen, GE) 
NaJ     Carl Roth GmbH (Karlsruhe, GE) 
6 M in TE-buffer 
Penicillin, streptomycin, glutamine (PSG): BioWest (Essen, GE) 
penicillin 50.000 U/l  
streptomycin 10 mg/l  
L-glutamine 292 mg/l  
Proteinase inhibitors:  Sigma Chemical Co. (Deisenhofen, GE) 
per ml (final concentration)  
1 mM PMSF (phenylmethylsulfonyl fluoride)  
100 µg trypsin/chymotrypsin inhibitor  
1 µg pepstatin  
5 µg antipain  
5 µg leupeptin  
1 µg aprotinin  
Solution 1 (for DNA preparation): 50 mM glucose  
10 mM EDTA  
25 mM Tris-HCl, pH 8.0  
Solution 2 (for DNA preparation): 0.2 mM NaOH  
1% w/v SDS  
Solution 3 (for DNA preparation): 3 M KAc, pH 4.8  
Trypsin-EDTA:   BioWest (Essen, GE) 
0.05% w/v trypsin (100 U/µl)  
0.02% w/v EDTA in PBS 
 
Buffers  
Denaturing buffer    0.5% w/v SDS  
1% v/v β-mercaptoethanol  
Electrophoresis buffer:   25 mM Tris  
                                                                                                 Materials and Methods 
28 
  (for SDS-PAGE)   250 mM glycine  
0.01% w/v SDS  
3x Laemmli buffer:    6% w/v SDS  
30% v/v glycerol 
150 mM Tris-HCl, pH 6.8  
0.02% w/v bromophenol blue 
150 mM DTT  
10x Ligation buffer:   0.5 M Tris pH 7.4 
     0.1 M MgCl2 
Matrix washing buffer:  50 mM NaCl 
     10 mM Tris pH 7.5 
2.5 mM EDTA 
50% EtOH  
PBS:     0.8% w/v NaCl  
  (phosphate buffered saline)  0.2% w/v KCl  
8 mM Na2HPO4  
1.5 mM KH2PO4  
pH 7.4; autoclaved 
6x sample buffer:    0.25% (w/v) bromophenol blue  
  (for agarose gels)   0.25% w/v xylencyanol 
30% v/v glycerol (in H2O)  
Separating gel buffer:  1.5 Tris-HCl, pH 8  
Stacking gel buffer:   1 M Tris-HCl, pH 6.8  
Standard lysis buffer:   25 mM Tris-HCl, pH 8.0  
  (for immunoprecipitation)  50 mM NaCl  
0.5% w/v sodium desoxycholate  
0.5% w/v Triton X-100  
TAE-buffer:     40 mM Tris-acetate  
1 mM EDTA, pH 8.0  
TE-buffer:    10 mM Tris-HCl  
1 mM EDTA, pH 8.0 
Washing buffer I:    0.5% v/v Triton-X-100 (in PBS)  
  (for immunoprecipitation)  0.005% w/v sodium desoxycholate in PBS  
Washing buffer II:    500 mM NaCl  
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  (for immunoprecipitation)  0.5% v/v Triton X-100  
10 mM EDTA  
125 mM Tris-HCl, pH 8.0 
 
2.1.5  Standards, systems, and software 
 
Molecular weight standards 
DNA standard (for agarose gels): 
As DNA marker a λ-phage-DNA - cleaved with the restricion enzymes EcoRI und 
HindIII - was used and purchased by MBI Fermentas (St. Leon-Rot, GE).  
 
fragment sizes (bp):  
21226, 5148, 4973, 4268, 3530, 2027, 1904, 1584, 1375, 947, 831, 564,125  
 
Protein standard: 
For the estimation of protein bands the standard SDS-6H (High Molecular Weight 
Standard Mixture for SDS Gel Electrophoresis; 29-205 kDa) from Sigma Chem. Co. 
(Deisenhofen, GE) was applied.  
 
protein:       molecular weight (kDa):  
myosin (rabbit muscle)     205  
ß-galactosidase (E.coli)     116  
phosphorylase B (rabbit muscle)    97.4  
albumine (bovine)      66  
albumine (chicken)      45  
carboanhydrase (bovine erythrocytes)  29 
 
Systems 
Metafectene™ Pro     Biontex (Martinsried, GE) 
Miniprep Express™ matrix   BIO 101 (La Jolla, USA) 
 
Software 
Image J software package    http://rsb.info.nih.gov/ij/ 
Quantity One®      BioRad (Munich, GE) 
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2.1.6  Equipment  
General equipment 
Vapor sterilizer (autoclave)    Integra Biosciences (Ruhberg, GE) 
Freezer –20 °C      Premium, Liebherr (Ochsenhausen, GE) 
Deep freezer –80 °C     C54285, New Brunswick Scientific 
       (Wesseling-Berzdorf, GE) 
Incubator       FunctionlineB12, Heraeus (Hanau, GE) 
Cooling centrifuge      Biofuge-fresco, Heraeus (Hanau, GE) 
Magnetic stirrer      RCT basic, IKA Labortechnik (Staufen, 
       GE)  
Photometer       Jenway, Genova (Staffordshire, UK) 
pH-Meter       PH538, WTW (Weilheim, GE) 
Precision balance      PT310, Sartorius (Goettingen, GE) 
Ultra-pure water supply     Milli Q, Millipore (Schwalbach, GE) 
Bench centrifuge      Biofuge-pico, Heraeus (Hanau, GE) 
Dry sterilizer      Heraeus (Hanau, GE) 
Vortexer       Minishaker MS2, IKA Labortechnik 
       (Staufen, GE) 
Water bath      E-BRU/PU19A, Jubalo (Seelbach, GE) 
 
Agarose gel electrophoresis 
Flat-bed apparatus, gel beds, combs   BioRad Laboratories (Munich, GE) 
Fluor-S
®
-Multiimager     BioRad Laboratories (Munich, GE) 
Chambers, Wide mini Sub
® 
Cell GT   BioRad Laboratories (Munich, GE) 
Power supply Power Pac 300    BioRad Laboratories (Munich, GE) 
UV-table      UVT-20 S/W, Herolab (Wiesloch, GE) 
 
SDS gel electrophoresis 
Glas plates, gel cast, combs, spacer   BioRad Laboratories (Munich, GE) 
Gel observer Molecular Imager
® 
FX,   BioRad Laboratories (Munich, GE) 
Gel chambers Protean
® 
II XI Cell,   BioRad Laboratories (Munich, GE) 
Gel drying device DC-3    Biometra (Goettingen, GE) 
Power supply Power Pac 1000    BioRad Laboratories (Munich, GE) 
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Phosphorimaging screens BAS-IP MS2025 Fujifilm Co. LTD (Duesseldorf, GE) 
 
Fluorescence microscopy 
Confocal laser scanning microscope TCS SP Leica Microsystems (Bensheim, GE)  
 
Cell culture 
Incubator Biosafe eco 70040    Integra Bioscience (Ruhberg, GE) 
Microscope DMIRB     Leica Microsystems (Bensheim, GE) 
Sterile bench Holten LaminAir S 2000 1.2  Thermo Fisher Scientific (GE) 
Tissue culture dishes, Falcon tubes, Transwell filters, and single-use pipetts 
Greiner (Hamburg, GE)  
 
PCR  
Programmable heater     Personal Cycler, Biometra  
       (Goettingen, GE) 
            Minicycler, MJ Research (Waltham,  
            MA, USA) 
 
2.1.7  Host bacteria 
Escherichia coli XL Gold 
Genotype:  
Tet
r 
∆ (mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte (F`proAB lacI
q
Z∆M15 Tn10 (Tet
r 
) Amy Cam
r
) 
a
, purchased by 
Stratagene  (Heidelberg, GE). 
 
2.1.8  Plasmids and oligonucleotides  
The mutation G1363S was introduced by site-directed mutagenesis into the wild type 
LPH cDNA cloned in the vector pSG5 (Stratagene, Amsterdam, The Netherlands) 
[Hoch, 2006] with the EcoRI sites of pLPH [Naim et al., 1991].1  
pcDNA3-LPH was generated by cloning the wild type LPH complementary DNA 
(cDNA) in the vector pcDNA3 (Invitrogen, Karlsruhe, GE) with the EcoRI sites of 
pLPH [Naim et al., 1991]. LPH was fused to YFP by subcloning the EcoRI/ScaI 
fragment from pcDNA3-LPH containing full-length LPH in-frame into the EcoRI/SmaI-
                                                 
1
 This was done by Melanie Hoch. 
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digested pEYFP-N1 vector (Clontech-Takara, Saint-Germain-en-Laye, France) to 
create pLPH-YFP. pLPH-GFP was generated as desribed previously [Jacob et al., 
2000]. SI-cherry was constructed by replacing YFP in SI-YFP [Jacob and Naim, 
2001] with cherry, an improved monomeric red fluorescent protein [Shaner et al., 
2004].2 
The applied oligonucleotides for ∆-mutant and domain constructs were purchased by 
Sigma Chem. Co. (Deisenhofen, GE) and are listed in Table 2.1 and Table 2.2. 
 
 
 
  
 
 
                                                 
2
 SI-cherry was generated by Zeynep Hein. 
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2.1.9  Cell lines 
COS-1 
COS-1 cells are derived from CV-1 monkey kidney cells from the African green 
monkey Cercopithecus aethiops. These cells were transformed with an origin-
defective SV40-mutant, which contains the wild type T-antigene [Gluzman, 1981]. 
The COS-1 cell line is an adherent, fibroblast-like, unpolar one, suitable for transient 
transfection with SV40-origin-of-replication-containing recombinant DNA.  
 
Madin Darby Canine Kidney II-cells (MDCK-II) 
The MDCK-II cell line is one strain of cells derived from cocker spaniel kidney cells 
isolated by S. H. Madin and N. B. Darby in 1958. These cells form a monolayer in 
vitro, and therefore are appropriate e. g. for the analysis of transport behavior of 
intestinal proteins [Leighton et al., 1969; Richardson et al., 1981]. 
 
All cell lines were obtained from the American Type Culture Collection (Rockeville, 
USA). 
 
 
2.2  Methods   
 
2.2.1  Manipulation of DNA  
 
2.2.1.1  Amplification of cDNA fragments (PCR) 
The polymerase chain reaction (PCR) [Saiki et al., 1988] is a method, with which 
copies of a particular DNA sequence can be generated specifically and in great 
numbers. For the amplification of particular LPH cDNA fragments a 50µl PCR 
reaction mixture comprised 50ng template DNA, 5µl 10x PCR buffer, 1µl dNTP mix, 
50pmol forward primer, 50pmol reverse primer, 1U Isis DNA polymerase and aqua 
bidest. The PCR parameter program included a pre-denaturation step (95°C for 
4min), 30 cycles of denaturation (95°C for 1min), annealing (55°C for 45sec), and 
elongation (2min/1kb at 72°C), as well as one final elongation step (72°C for 10min). 
The reaction was carried out in a heated-lid (98°C) thermocycler and performed as 
hot-start PCR, whereby the polymerase was added after the pre-denaturating step to 
avoid unspecific products. 
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2.2.1.2  Generation of sticky ends by restriction digestion 
Before ligation, PCR product ends were digested with restriction enzymes (5U) within 
the reaction mixture to generate sticky ends. Moreover, the vector was prepared for 
ligation by mixing plasmid DNA (5µg), aqua bidest., enzyme buffer, and restriction 
enzymes (5U). The mix was incubated at optimal enzyme working temperature for 
2h. 
 
2.2.1.3  Agarose gel electrophoresis 
After the reactions were finished the complete mixtures were added to 1/5 volume of 
6x sample buffer and loaded on a 0.8% ethidium bromide stained agarose/TAE gel. 
The PCR product, the vector, and the λ-DNA standard were separated with 120V, the 
gel was analyzed by visualizing the DNA on a UV-table, and the bands 
corresponding to the LPH fragment and the vector, respectively, were cut out from 
the gel. Subsequently, the DNAs were isolated from the gel pieces and purified with 
Miniprep Express™ matrix.  
 
2.2.1.4  Purification of DNA from agarose gels 
The gel pieces were put into a 1.5ml tube, overlayed with 6M NaJ, and incubated at 
52°C until the gel has melted. Then, the matrix was resuspended by vortexing, 100µl 
were added to the DNA, and the mixture was incubated at 52°C for 5min. After 
resuspension of the pellet, incubation was repeated, and the DNA-matrix pellet was 
washed three times with matrix washing buffer. The DNA was eluted by adding 10µl 
of aqua bidest. to the pellet and incubation at 52°C for 5min. The elution step was 
repeated, the eluates were combined, and the DNA concentration was determined. 
 
2.2.1.5  Determination of DNA concentration via band intensity comparison 
From the eluate, 2µl were mixed with 8µl aqua bidest. and 2µl 6x sample buffer. The 
mix and different amounts of λ-DNA standard were loaded on a 0.8% ethidium 
bromide stained agarose/TAE gel. After the gel run the sample band intensity was 
compared to the marker bands intensities which correspond to known DNA amounts 
and by that the sample DNA amount could be determined. 
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2.2.1.6  Ligation  
For ligation of the LPH cDNA fragment into a vector, the total volume of the ligation 
mixture was 20µl. Generally, the number of insert molecules was 3 to 4 times of the 
acceptor molecules and the total DNA amount did not exceed 80ng. Before ligation, 
vector and insert DNA were incubated at 37°C for 5min in the required volume of 
aqua bidest. Then, the DNA was put on ice and 2µl of 10x ligation buffer, 1µl of 20x 
DTT (0.2M), 2µl of 10x ATP (10mM), as well as 1µl T4 ligase (5U) were added. The 
mix was pipetted up and down, spinned down, and incubated for 4h at room 
temperature or over night at 16°C. Subsequently, T4 ligase was inactivated by 
incubation at 65°C for 10min, the ligation mix was put on ice, and 5µl was used for 
transformation of 100µl competent E.coli. 
 
2.2.1.7  Generation, transformation, and storage of competent E.coli 
Generation and transformation of competent E.coli was performed according to Inoue 
[Inoue et al., 1990]. Competent E.coli were stored at –80°C. 
 
2.2.1.8  Isolation of plasmid DNA from E.coli    
Bacterial colonies grown on LB agar plates with selective medium were used for the 
inoculation of 5ml over night fluid cultures and bacteria grew at 37°C in a shaker. 
Plasmid DNA was isolated from E.coli  by the rapid alkaline extraction procedure of 
Birnboim and Doly [Birnboim and Doly, 1979], purified and concentrated via ethanol 
precipitation. The DNA pellets were resuspended in TE-buffer and the over night 
culture remainders were stored in the refrigerator until the identification of positve 
clones.   
 
2.2.1.9  Identification of positive clones by fragment restriction analysis 
Putative positive clones were identified by fragment restriction analysis. For that, 2µl 
of the DNA from the over night clultures were mixed with aqua bidest., restriction 
enzyme buffer, and 2U of one or more restriction enzymes according to the 
manufacturers recommendation and dependent of the supposed recombinant DNA 
molecule. As a control, empty vector DNA was digested also. After incubation at the 
enzyme-specific temperature for at least 2h, the reaction was stopped by adding 1/5 
volume of 6x sample buffer. Sample, control and marker DNA was separated on an 
ethidium bromide stained agarose gel, and the restriction patterns were analyzed by 
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visualizing the DNA on a UV-table. Overnight culture remainders of positive clones 
were mixed with glycerol to 50% v/v and stored at –80°C. 
 
2.2.1.10  Large-scale DNA preparation  
In order to receive large amounts of plasmid DNA, 10µl of a small over night culture 
or a piece from a glycerol culture were used to inoculate 200ml of LB selection 
medium. Bacteria were incubated at 37°C over night in a shaker and were afterwards 
centrifuged at 5000xg for 5min. The rapid alkaline extraction procedure of Birnboim 
and Doly [Birnboim and Doly, 1979] was performed as follows. 
The pellet was resuspended in 8ml solution 1 with RNAse A and incubated for 10min 
at room temperature. Then, the cells were lysed by adding 16ml of solution 2 and 
gently mixing, as well as incubation for another 10min at room temperature. 
Subsequently, 12ml of solution 3 were added, mixed gently, and incubated on ice for 
10min. The precipitate of chromosomal DNA and proteins was removed by filtering 
the mixture through two folded filters. The flow-through was added to 0.8x volumes of 
isopropanol, mixed intensively, and centrifuged for 20min at 15000xg and 4°C to 
precipitate plasmid DNA. The Pellet was washed with 70% ethanol and centrifuged 
again for 5min at 15000xg and 4°C. The pellet was dried and resuspended with 600µl 
TE-buffer. 
For further purification, the DNA was mixed with 1 volume of phenol, centrifuged for 
15min at 15000xg and 4°C. The resulting upper watery phase was transferred to 
another tube, mixed with 1 volume of chloroform, and centrifuged for 2min at 
15000xg. This washing step was repeated once. To precipitate plasmid DNA, the 
upper watery phase was again transferred to another tube, mixed intensively with 
0.8x volumes of isopropanol and 150mM sodium acetate (pH 7.4; final 
concentration), and centrifuged for 20min at 12000xg and 4°C. The pellet was 
washed with 70% ethanol, dried, and resuspended in 200-500µl of TE-buffer 
(depending on the pellet size). 
 
2.2.1.11  Determination of DNA concentration via UV-light 
The DNA concentrations of solutions from large-scale DNA preparation were 
determined by measuring the UV-absorption at 260nm and application of a quartz 
cuvette with a thickness of 1cm. The purity of nucleic acids was estimated by the 
ratio of extinctions at 260nm and 280nm, whereby the optimum is between 1.8 and 2. 
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2.2.1.12  Site-directed mutagenesis and loop-out PCR 
In order to change only small parts of a cDNA, e. g. single nucleotides, site-directed 
mutagenesis was performed. Here, two complementary oligonucleotides carrying 
both a mutation were used as primers. They bind double-stranded plasmids 
sequence-specifically during a PCR and are elongated by the DNA-polymerase; the 
PCR products are complete plasmids carrying the mutation. The template plasmids 
were eliminated afterwards by adding DpnI (5U per PCR) and incubation for 2h at 
37°C. The restriction enzyme DpnI digests the methylated template DNA, but not the 
non-methylated PCR products. Subsequently, DpnI was inactivated at 65°C for 
10min, the mixture was cooled down on ice and 5µl were used for transformation 
followed by subsequent experiments (cp. 2.2.1.7 - 2.2.1.11). In order to facilitate a 
rapid detection of positive clones by restriction fragment analysis, a second (silent) 
mutation had been introduced in the oligonucleotides, resulting in either an 
elimination or addition of a restriction site but not in changes of amino acids. 
For the deletion of a larger cDNA area a special form of site-directed mutagenesis 
was applied, namely loop-out PCR. Here, the primers are designed in a way, that the 
first half of one oligonucleotide is complementary to the sequence directly in front of 
the area to be deleted, and the second half is complementary to the area localized 
directly behind the cDNA area to be deleted. During the annealing and elongation 
step of the PCR, the template cDNA area to be deleted forms a loop while the 
primers bind in front and behind it. This loop is not amplificated and the result is a 
smaller plasmid, with a cDNA deleted in part. 
The carrying out of the mutagenesis PCR differed from the PCR described above 
(cp. 2.2.1.1) in some points. Firstly, only 5pmol per primer were used. Secondly, 
because of the amplification of whole plasmids, the elongation times were longer and 
only 18 cycles of denaturation, annealing, and elongation were performed. Thirdly, 
the PCR mixture was used directly for transformation after incubation with DpnI. 
 
2.2.1.13  DNA Sequencing 
The correctness of every generated construct was verified by sequencing. This was 
done by MWG (Ebersberg, GE) according to the companies protocols. 
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2.2.2  Cell culture procedures and transfection 
 
2.2.2.1  Transient transfection of COS-1 cells 
COS-1 cells were transiently transfected with DNA using DEAE-dextran essentially 
as described previously [Naim et al., 1991]. 
 
2.2.2.2  Establishment of stable MDCK-II cell lines 
MDCK cells were transfected using Metafectene™ Pro following manufacturer’s 
instructions. Stable transfected MDCK cells were selected in the presence of 
0.5mg/ml active G418 and after 14-21 days colonies were isolated, subcultured and 
stable transformants were screened by immunoprecipitation. 
 
 
2.2.3  Isolation, detection, and analysis of proteins  
 
2.2.3.1  Biosynthetic labeling 
The cells were biosynthetically labeled with 80 µCi of [35S]methionine in MEM after 
2h of incubation with methionine-free MEM. Labeling was either performed 
continuously or following a pulse-chase protocol where the labeled cells were chased 
with non-radioactive methionine for different periods of time. 
 
2.2.3.2  Standard cell lysis and immunoprecipitation 
Standard cell lysis and immunoprecipitation of LPH from detergent extracts of the 
labeled cells was performed according to Naim et al. [Naim, 1987] using a mixture of 
mAb anti-LPH (HBB 1/909 and MLac1, MLac2, MLac4, MLac6 and MLac10) and 
V496. This mixture recognizes different conformations of LPH. GFP- and FLAG-
tagged proteins were isolated with anti-GFP and anti-FLAG antibodies, respectively. 
 
2.2.3.3  Manipulation of glycosylation 
Deglycosylation 
A further characterization of glycoproteins can occur by the use of endoglycosidases 
[Maley et al., 1989]. Immunoprecipitates were treated with endo H or endo F where 
indicated according to Naim et al. [Naim, 1987] followed by analysis using SDS-
PAGE. 
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Inhibition of glycosylation 
To test the role of inhibitors of the maturation process of D3, inhibitors of 
glycosylation were separately added to the medium during the preincubation of 
MDCK-D3 cells in methionine-free medium as well as during the labeling with 
[35S]methionine. Benzyl-GalNAc was used as an inhibitor of O-glycosylation at 4mM 
final concentration, whereas monensin as inhibitor of N-glycosylation was given to 
cells at 1µM final concentration. 
 
2.2.3.4  Trypsin treatment of immunoprecipitates 
To assess the sensitivity of the mutants to trypsin, immunoprecipitated proteins were 
washed for additional two times with PBS containing 0.2% Triton X-100, were 
supplemented with 10 µg bovine serum albumin (BSA) as a carrier and incubated 
with 0.33 mg/ml trypsin for the indicated times at 37°C. The reaction was stopped by 
boiling for 5 min in SDS-PAGE sample buffer prior to gel electrophoresis.  
 
2.2.3.5  Trypsin treatment of COS-1 cell surface proteins 
Detection of deletion mutants at the cell surface was performed by adding 50µg/ml 
trypsin to the cell culture medium for 15min at 37°C during biosynthetic labeling or 
chase period to remove LPHα. The reaction was stopped by incubating the cells with 
cold FCS containing 500µg/ml trypsin inhibitor for 15min at room temperature. 
 
2.2.3.6  Enzymatic activity assay 
Lactase and phlorizin-hydrolase activities were assessed as follows. The 35S-labeled 
immunoprecipitates were washed with PBS containing 0.2% Triton X-100 and 
incubated with 100 µl of this buffer containing lactose or phlorizin at 28 mM final 
concentrations. The samples were incubated at 37°C for 2h and the amount of 
released glucose was assessed by high-performance liquid-chromatography 
(HPLC).3 The quantification of the specific activity was related to the radioactive 
protein band detected by autoradiography and the number of methionines for each 
construct. 
 
 
                                                 
3
 HPLC was performed by Uwe Glockenthör. 
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2.2.3.7  SDS-polyacrylamide gel electrophoresis  
One-dimensional SDS-polyacrylamide gel electrophoresis was performed according 
to Laemmli [Laemmli, 1970]. 
 
stacking gel:    separating gel: 5% 6% 7% 9% 10% 
aqua bidest. (ml) 15.6   aqua bidest. (ml) 17.5 16.5 15.5 13.4 12.3 
Acrylamide (ml) 3.9   Acrylamide (ml) 5.2 6.2 7.2 9.2 10.3 
1M Tris, pH 6.8 (ml) 2.9   1.5M Tris, pH 8.8 (ml) 7.7 7.7 7.7 7.7 7.7 
10% SDS (µl) 230   10% SDS (µl) 310 310 310 310 310 
TEMED (µl) 23   TEMED (µl) 23 23 23 23 23 
10% APS (µl) 230   10% APS (µl) 310 310 310 310 310 
 
Table 2.3: Ingrediens for polyacrylamide gels. 
 
The radioactively labeled protein bands were visualized by phosphorimaging. Protein 
bands were quantified with Quantity One® software. 
 
2.2.3.8  Immunofluorescence 
Immunofluorescence was performed essentially as described previously [Castelletti 
et al., 2006]. 
 
2.2.3.9  Confocal fluorescence microscopy 
COS-1 cells grown on cover slips were transfected and confocal images of living 
cells were acquired 2 days after transfection on a Leica TCS SP2 microscope with a 
x63 water planapochromat lens (Leica Microsystems, Bensheim, GE) [Jacob and 
Naim, 2001] and processed with the public domain Image J software package. For 
colocalization studies the cells were co-transfected with GFP- or YFP-tagged LPH 
cDNA or the mutant LPH cDNA and the protein marker for the ER dsRed2-ER and 
for the Golgi apparatus Golgi-CFP (Clontech-Takara, Saint-Germain-en-Laye, 
France). 
 
2.2.3.10  Cell lysate fractionation on sucrose density gradients  
Quaternary structures of LPH wild type and mutants were analyzed according to 
Naim [Naim and Naim, 1996]. In brief, COS-1 cells were biosynthetically labeled and 
solubilized in 6mM dodecyl-β-m-maltoside, 50mM Tris-HCl, 100mM NaCl, pH 7.5 and 
protease inhibitors. The cell extracts were centrifuged at 100000xg for 1h at 4°C and 
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the supernatant was loaded onto an 11.5ml sucrose gradient that consisted of 10 to 
30% or 15 to 25% sucrose (w/v), 50mM Tris-HCl, 100mM NaCl, pH 7.5, 6mM 
dodecy-β-m-maltoside and the protease inhibitors mentioned above except PMSF. 
The gradient was centrifuged at 100000xg for 18h at 4°C and divided into 0.5ml 
fractions followed by immunoprecipitation and SDS-PAGE. 
 
 
2.2.4  Extraction of detergent resistant lipid microdomains 
Extraction of detergent resistant lipid microdomains was performed essentially as 
described previously  [Castelletti et al., 2008].  
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3.  Results  
         
3.1  Impaired trafficking and subcellular localization of a mutant 
   lactase associated with congenital lactase deficiency  
 
3.1.1 Location and description of the Gly1363 mutation in CLD 
Diseases caused by one or more defects in one gene can result in individually 
different phenotypic appearances like those observed in cases of congenital sucrase-
isomaltase deficiency [Fransen et al., 1991; Keiser et al., 2006; Naim et al., 1988]. 
Recently, nine distinct mutations in the coding region of the lactase gene have been 
identified in patients suffering from congenital lactase deficiency (CLD), one of them 
is G1363S [Kuokkanen et al., 2006; Torniainen et al., 2009]. Table 3.1.1 compiles the 
LPH primary sequence in different species and demonstrates that the residue Gly1363 
is conserved. This together with the generation of a potential N-glycosylation site (cp. 
1.1.4, Glycosylation) as result of G1363S exchange suggests that these amino acids 
play crucial roles in the context of folding determinants.  
 
 
Table 3.1.1: Comparison of the amino acid stretch encompassing the mutation 
G1363S. Sequence alignment between amino acids 1353 to 1373 of LPH from 
different species, indicating important functions of this region.  
 
 
 
3.1.2 The G1363S mutation results in an intracellular localization and altered  
    biosynthesis and processing of LPH  
The influence of the residue Gly1363 on the folding and transport events of newly 
synthesized LPH was investigated by highlighting possible differences between wild 
type LPH and LPH bearing the G1363S mutation. Since this mutation appeared as a 
compound heterozygote together with an Y1390X mutation in the same patient 
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[Kuokkanen et al., 2006], it was also asked if this amino acid substitution per se can 
influence the enzyme function. For this, the mutation G1363S was introduced into 
wild type LPH (indicated LPH-G1363S). 
 
Fig. 3.1.1 shows a schematic drawing of the structure and membrane association of 
LPH as well as the location of the mutation G1363S in the homologous domain III 
that comprises the phlorizin-hydrolase activity.  
 
Fig. 3.1.1: Location of the G1363S mutation in LPH. Main features of intestinal 
LPH structure. Prepro-LPH consists of a cleaveable signal sequence (SS; Met1-Gly19) 
and an extracellular region comprising homologous domains I-IV (Ser20-Thr1882). The 
initial cleavage step takes place between Arg734 and Leu735 generating LPHβinitial, 
removal of the polypeptide stretch Leu735/Arg868 occurs by a luminal trypsin creating 
LPHßfinal. Cleavage and mutation sites are indicated by arrows, location of the 
phlorizin-hydrolase (Glu1273) and lactase (Glu1749) activities, respectively, are 
indicated by asterisks. MACT refers to the membrane anchor (MA) and cytoplasmic 
tail (CT). 
 
The LPH-G1363S mutant and its wild type counterpart were expressed in COS-1 
cells (Fig. 3.1.2), biosynthetically labeled and immunoprecipitated with anti-LPH 
antibodies. Fig. 3.1.2 (upper panel) shows that wild type LPH revealed an endo H-
sensitive 215-kDa mannose-rich polypeptide within 1.5 h of labeling. Another 
glycosylated 230-kDa protein band appeared at 8 h of labeling that was endo H-
resistant and represents therefore a complex glycosylated mature band that has 
been processed in the Golgi apparatus. By contrast, the LPH-G1363S mutant 
revealed exclusively an endo H-sensitive 215-kDa glycosylated protein that retained 
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its mannose-rich type of glycosylation even after 8 h of labeling and has not been 
therefore processed in the Golgi apparatus (Fig. 3.1.2, lower panel).  
 
 
Fig. 3.1.2: Expression of wild type and mutant LPH in COS-1 cells. COS-1 cells 
were transiently transfected with cDNAs encoding wild type LPH
 
and LPH-G1363S, 
biosynthetically labeled for 1.5h and 8h followed by cell lysis and 
immunoprecipitation. The immunoprecipitates were divided into equal aliquots and 
treated with endo H or not treated. The proteins were subjected to SDS-PAGE on 5% 
slab gels and autoradiography. 
 
 
The biochemical data were corroborated by immunofluorescence analyses of the 
subcellular and cell surface localization of the wild type and mutant LPH-G1363S 
using confocal laser microscopy. As shown in Fig. 3.1.3 cell surface labeling revealed 
strong labeling of wild type LPH at the cell surface in contrast to LPH-G1363S which 
was barely detected (upper panel). In permeabilized cells, LPH-G1363S was 
predominantly located in intracellular compartments. In fact, LPH-G1363S was found 
to colocalize with an ER marker. Taken together, the biochemical and 
immunofluorescence data indicate that the LPH-G1363S mutant does not exit the 
ER. 
 
                                                                                                                           Results 
45 
 
 
 
Fig. 3.1.3: Subcellular localization of LPH-G1363S in transiently transfected 
COS-1 cells. A) Wild type and mutant LPH forms were expressed in COS-1 cells 
grown on cover slips and their cell surface and subcellular localization was compared 
by immunofluorescence and confocal microscopy. B) Colocalization of wild type and 
mutant proteins with the ER marker DsRed2-ER (colocalizations are shown in 
yellow). Scale bars, 20 µm. 
A 
B 
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3.1.3 Mutant LPH-G1363S is a malfolded and enzymatically inactive protein 
Given the predominant intracellular location of the mutant LPH-G1363S, one 
question was whether the trafficking arrest is the consequence of gross structural 
alterations elicited by the mutation G1363S. Firstly, the enzymatic activity of the 
mutant towards lactose and phlorizin were determined and were found to be below 
detection limit (Fig. 3.1.4). These measurements are indicative of an altered folding of 
at least around the activity centers of phlorizin-hydrolase, Glu1273, and lactase, 
Glu1749 (cp. Fig. 3.1.1).   
 
 
Fig. 3.1.4: Enzymatic activity of LPH and LPH-G1363S. COS-1 cells were 
transiently transfected with wild type and mutant LPH cDNA. 48h posttransfection the 
cells were lysed and immunoprecipitated with mAb anti-LPH, and the lactase and 
phlorizin activities were measured by determining the concentration of released 
glucose with HPLC.
 
    
Then, the enzymatic measurement data were corroborated by comparing the 
protease sensitivity of wild type and mutant LPH-G1363S towards trypsin. In the 
intestinal lumen a pancreatic trypsin cleaves wild type LPHβinitial upon insertion into 
the brush border membrane to generate LPHβfinal, which is trypsin resistant (cp. Fig. 
3.1.1). As such trypsin is a convenient protease that could be used to probe possible 
folding alterations, whereby variations in the tryptic digestion pattern are indicative of 
a conformational change in LPH. 
For this, wild type and mutant LPH were isolated from biosynthetically labeled COS-1 
cells that are known not to cleave pro-LPH to LPHβinitial intracellularly [Naim et al., 
1991]. Subsequently, the immunoprecipitates were treated with trypsin at a 
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concentration capable of cleaving wild type LPH into the profragment and LPHβfinal. 
As shown in Fig. 3.1.5 at 0 min of trypsin treatment, wild type LPH consisted of two 
bands, the mannose-rich 215-kDa form, and the complex-glycosylated 230-kDa form. 
2 min of trypsin treatment were sufficient to convert both forms to 160-kDa and 135-
kDa polypeptides. The intensities of these polypeptides did not significantly change 
after 10 min of trypsin treatment strongly suggesting that no additional trypsin sites 
were exposed in wild type LPH4. LPH-G1363S appeared as a mannose-rich 215-kDa 
species after 0 min and was completely degraded within 2 min. The marked 
difference in the reactivity of this mutant and wild type LPH is indicative of altered 
folding patterns. 
 
 
 
 
Fig. 3.1.5: Folding of wild type and mutant proteins.  Trypsin sensitivity assay of 
LPH
 
and LPH-G1363S. Transiently transfected COS-1 cells were biosynthetically 
labeled at 37°C followed by immunoprecipitation of LPH proteins from the cell 
lysates. The immunoprecipitates were treated with trypsin for the indicated times and 
analyzed by SDS-PAGE.  
 
 
3.1.4 The mutation G1363S is responsible for an increased turnover rate of 
    LPH-G1363S as compared with wild type LPH 
The fate of the malfolded mutant was next addressed by delineating its trafficking 
kinetics as compared to the wild type protein utilizing pulse-chase experiments (Fig. 
                                                 
4
 The profragment LPHα is not shown, since it is further cleaved by trypsin to a lower molecular weight 
that runs at the front of the gel. 
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3.1.6). The conversion of the 215-kDa mannose-rich precursor to the complex 
glycosylated 230-kDa form occurs only for the wild type protein between 0.5 h and 
1 h of chase (upper panel). By contrast, the LPH-G1363S mutant persisted as a 
mannose-rich glycosylated protein through out the chase and its intensity started to 
decrease at 4 h of chase with clear reduction observed at 8 h and 12 h of chase 
(lower panel) pointing to its degradation in the ER, perhaps by the ER-associated 
degradation pathway (ERAD) [Nakatsukasa et al., 2008]. The intensity of the 
complex glycosylated wild type LPH decreases also, but not to a similar extent as the 
mutant protein compatible with a longer turnover rate of the wild type as compared to 
the mutant.   
 
 
Fig. 3.1.6: Transport kinetics and turnover of wild type and mutant proteins. 
Transiently transfected COS-1 cells were pulsed with [35S]methionine followed by 
chases for different times at 37°C. Cells were lysed, and the immunoprecipitates 
were analyzed by SDS-PAGE and autoradiography.  
 
3.1.5 LPH-G1363S is a temperature-sensitive mutant 
The majority of naturally occurring mutants that are implicated in diseases are not 
capable of escaping the quality control machinery of the ER and are retained in that 
organelle. However, a few mutant phenotypes differ from this general scheme with 
respect to their in vitro sensitivity towards reduced non-physiological temperatures 
and the acquisition at these permissive temperatures to a partially correctly folded 
conformation that enables them to exit the ER. Known examples of this type of 
mutants are phenotype II in congenital sucrase-isomaltase deficiency [Propsting et 
al., 2005], the DeltaF508 mutant of the cystic fibrosis transmembrane conductance 
regulator [Cheng et al., 1990] and the temperature-sensitive ts045 mutant of the G 
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protein of the vesicular stomatitis virus [Doms et al., 1987]. Finally, individual 
expression of LPHβinitial without its LPHα profragment at a permissive temperature of 
20°C generates a stable, trypsin-resistant, and an enzymatically active polypeptide 
indicating that its individual expression results in a temperature-sensitive 
conformation [Jacob et al., 2002a]. 
Therefore the question arose whether LPH-G1363S belongs to this family of 
transport-defective mutants and meets the requirements of a temperature-sensitive 
mutant. For this, the influence of reduced temperatures on the trafficking behavior of 
LPH-G1363S was investigated in a pulse-chase experiment. Fig. 3.1.7 shows that 
biosynthetic labeling of cells expressing LPH-G1363S at a permissive temperature of 
20°C revealed a complex glycosylated endo H-resistant protein band after 22 h of 
labeling. The proportion of the complex glycosylated form, on the other hand, was 
clearly below that detected for the wild type under similar labeling conditions. 
Nevertheless, the results unequivocally demonstrate that the mutant LPH-G1363S is 
temperature-sensitive and has been transported to and processed in the Golgi 
apparatus at the permissive temperature. The control sample in which the mutant 
was chased for 10 h at 37°C showed exclusively the mannose-rich polypeptide of 
mutant LPH-G1363S, while as expected the wild type revealed complex glycosylated 
forms under these conditions. Interestingly, complex glycosylated LPH-G1363S form 
is slightly larger than that of the wild type protein. This becomes more obvious when 
the patterns of the endo H-digested proteins are considered. Here, the difference in 
the electrophoretic mobilities of the endo H-products of the LPH-G1363S
 
mutant is 
clearly higher than that of its wild type counterparts. This result demonstrates that 
LPH-G1363S is more glycosylated than the wild type protein and that the additional 
N-glycosylation site generated by the mutation (cp. Table 3.1.1) has been accessible 
to glycan transfer. The maturation of LPH-G1363S at 20°C is sufficient for its 
transport to the cell surface, when the temperature is raised to 37°C. In fact, 
immunofluorescence analysis of cells expressing LPH-G1363S that have been 
cultured at 20°C for 22 h followed by 2 h chase at 37°C reveal strong fluorescence 
signals corresponding to LPH-G1363S exposed at the cell surface (Fig. 3.1.7). 
Finally, the question arose whether the observed transport-competence is due to 
acquired correct folding and probed therefore for its protease sensitivity with trypsin. 
The protein maintained its trypsin-sensitivity and was completely degraded in 
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contrast to the wild type protein, which revealed as shown above the trypsin-resistant 
polypeptides (160-kDa and 135-kDa) [Behrendt et al., 2009].  
 
 
 
            
Fig. 3.1.7: Biosynthesis, transport kinetics, glycosylation pattern, and 
subcellular localization of wild type LPH and LPH-G1363S at 37°C and 20°C. A) 
Transiently transfected COS-1 cells were pulsed 48h after transfection with 
[35S]methionine and chased for the indicated time points at 37°C, 20°C or both and 
treated with endo H or endo F or not treated. B) COS-1 cells grown on cover slips 
and expressing wild type LPH and LPH-G1363S were cultured at 20°C followed by 
incubation at 37°C. The subcellular localization was compared by 
immunofluorescence and confocal laser microscopy. Scale bars, 20 µm. 
 
 
Further, the enzymatic activity pattern of the mutant at the permissive temperature 
was assessed and a slight increase in the activity towards lactose and phlorizin could 
be detected (Fig. 3.1.8). Together, these results demonstrate that LPH-G1363S did 
A 
B 
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not acquire a folding pattern similar to that of the wild type LPH at the permissive 
temperature. Nevertheless, this partial folding is apparently sufficient for proteins to 
leave the ER in line with novel concepts that have proposed the existence of quality 
control mechanisms beyond the ER and contradicting previous concepts of the 
absolute requirement for correct folding prior to exit from the ER [Ellgaard and 
Helenius, 2003]. 
 
Fig. 3.1.8: Enzymatic activity of LPH and LPH-G1363S after incubation at 20°C. 
COS-1 cells were transiently transfected with wild type and mutant LPH cDNA. 48h 
posttransfection the cells were incubated at 20°C and 37°C, lysed and 
immunoprecipitated with anti-LPH antibodies, and the lactase and phlorizin activities 
were measured by determining the concentration of released glucose with HPLC. 
The error bars represent standard deviations. 
 
 
3.1.6 The potential glycosylation site generated by the G1363S mutation is 
    not the cause of defective trafficking of LPH-G1363S or its reduced 
    enzymatic activity 
Recent data show that addition of N-glycosylation sites can alter protein features as 
quaternary  structure, transport [Jacob et al., 2000] and sorting [Vagin et al., 2005]. It 
was therefore necessary to elucidate, if the additional glycosylation of LPH-G1363S 
is the reason for impaired folding and trafficking of the protein. For this, the additional 
N-glycosylation site was re-eliminated by generating another mutant containing the 
amino acid substitutions N1361A and G1363S, denoted LPH-N1361A/G1363S. In a 
fashion similar to LPH-G1363S, this mutant was not capable of exiting the ER at 
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37°C, and showed a similar pattern to LPH-G1363S at 20°C (Fig. 3.1.9), suggesting 
that the additional glycosylation does not alone lead to altered LPH characteristics in 
LPH-G1363S. 
 
 
 
 
Fig. 3.1.9: Biosynthesis and glycosylation pattern of wild type LPH, LPH-
G1363S and LPH-N1361A/G1363S at 37°C and 20°C. COS-1 cells were transiently 
transfected with the cDNAs encoding LPH or its mutants. 48h after transfection the 
cells were continuously labeled (A) or pulse labeled and chased at 20°C and 37°C 
(B). LPH proteins were immunoprecipitated and treated with endo H or endo F or not 
treated and analyzed by SDS-PAGE on 5% slab gels followed by autoradigraphy. 
Arrowheads indicate the complex glycosylated 235-kDa LPH-G1363S protein form. 
 
 
A 
B 
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3.2  Structural hierarchy of regulatory elements in the folding and 
    transport of an intestinal multi-domain protein:  
    Domain III constitutes the structural core while domain IV 
    has a regulatory role  
      
LPH comprises four extracellular regions which contain 38-55% identical residues 
[Mantei et al., 1988]. An interval of about 100 amino acids within each domain is 
even more homologous and this internal homology can also be found by comparison 
of LPH primary sequences of different species. While the function of domains I and II 
that constitute the profragment or proregion of LPH, LPHα, has been assessed 
before and shown to act as an intramolecular chaperone [Jacob et al., 2002a], the 
individual roles of the two other domains III and IV are poorly understood. Homology-
based models of domains III and IV reveal typical TIM-barrel structures of family 1 
glycoside hydolases and show distinct differences between these two domains 
[Behrendt et al., 2010]. The impact of these homologous domains on the generation 
of a transport-competent configuration of pro-LPH was addressed in conjunction with 
the question of whether either domain can fold independently. For this, several cDNA 
constructs each lacking the coding region of one homologous domain were 
generated (Fig. 3.2.1, B). Previous in silico analysis provided the potential domain 
boundaries as a basis for site-directed loop-out mutagenesis.5 For better 
comparability, the main structural and functional features of human intestinal LPH are 
given in Figure 3.2.1, A. 
 
 
 
                                                 
5
 This was done by Julio Polaina, Instituto de Agroquímica y Tecnología de Alimentos, Consejo 
Superior de Investigaciones Científicas, Apdo. de Correos 73, Burjassot, Valencia, E46100, Spain. 
A 
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Fig. 3.2.1: Schematic presentation of wild type and LPH deletion mutants. A) 
Main features of intestinal LPH structure. B) Schematic drawing of domain deletion 
mutants generated by loop-out mutagenesis. Location of phlorizin hydrolase (Glu1273) 
and lactase (Glu1749) activities, respectively, are indicated by stars. MACT, 
membrane anchor and cytoplasmic tail. 
 
 
3.2.1  Expression of wild type pro-LPH and domain deletion mutants in COS-1 
 cells   
To examine the contribution of each of the two homologous domains to the structural, 
functional and trafficking features of LPH, the LPH deletion mutants were expressed 
in COS-1 cells and their characteristics compared to those of wild type LPH (Fig. 
3.2.2). Cell lysates were immunoprecipitated and the precipitated proteins were 
treated with endo H to determine their glycosylated state as a measure of trafficking 
capacity. LPH∆4 acquired endo H-resistance concomitant with complex glycosylation 
in and trafficking of these mutants to the Golgi apparatus. By contrast, the mutant 
lacking homologous domain III, LPH∆3, was not transport-competent and the 
introduction of a spacer containing seven glycines to avoid possible sterical 
hindrances did not alter its trafficking characteristics. Assessment of the proportions 
of the mannose-rich and complex glycosylated forms after scanning of the gels 
revealed a substantial increase in the proportion of the complex glycosylated LPH∆4 
as compared to the wild type counterpart. This was surprising, since it indicated that 
the deletion of domain IV in LPH∆4 leads to a more rapid processing of this deletion 
mutant than the wild type protein. 
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Fig. 3.2.2:  Glycosylation pattern of LPH wild type and domain deletion mutants 
in COS-1 cells. A) Transiently transfected COS-1 cells were biosynthetically labeled 
for 8h with [35S]methionine followed by immunoprecipitation. The immunoprecipitates 
were divided into two aliquots and treated with endo H, or not treated. The proteins 
were subjected to SDS-PAGE followed by autoradiography. B) densitometric 
scanning of the endo H treated biosynthetic forms of wild type and mutant LPH 
shown in (A). 
 
 
The subcellular distribution of the mutant proteins was further investigated in more 
detail by confocal laser microscopy. As shown in Figure 3.2.3, LPH∆3 was retained 
intracellularly and colocalized with the ER-DsRed marker. By contrast, and consistent 
with the biochemical data LPH∆4 colocalized with markers of the ER, Golgi and was 
detected at the plasma membrane in a fashion similar to the wild type protein.  
A 
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Fig. 3.2.3:  Subcellular distribution of LPH wild type and domain deletion 
mutants in COS-1 cells. A) confocal analysis of transfected COS-1 cells. B-C), 
colocalization of LPH mutants with ER and Golgi markers, respectively, in transfected 
COS-1 cells. COS-1 cells were co-transfected with GFP-tagged LPH proteins and 
ER-DsRed or YFP-tagged LPH proteins and galactosyl transferase (GT)-CFP, 
respectively. Confocal analysis with living cells was performed 48h after transfection. 
n, nucleus; arrowheads, cell surface; bars, 20 µm. 
 
3.2.2 Requirements for the LPH deletion mutants to exit the ER  
Dimerisation of LPH in the ER is absolutely required for LPH to egress this organelle 
to the Golgi apparatus [Naim and Naim, 1996]. The differential intracellular 
distribution and maturation patterns of the deletion mutants as well as the variable 
proportions of the glycoforms have altogether lead to examine the quaternary 
structures of the mutants and assess their relevance to their transport out of the ER. 
Fig. 3.2.4 depicts the results obtained using sucrose density gradients. As has been 
previously shown, the mannose-rich LPH form was retained in the light as well as 
dense gradient fractions concomitant with its monomeric and dimeric states 
respectively and indicative of dimerisation occurring along the early secretory 
pathway. The complex glycosylated protein on the other hand is detected exclusively 
in the dense fractions indicating that the dimerisation of the mannose-rich form of 
LPH precedes its complex glycosylation and maturation in the Golgi [Naim and Naim, 
1996]. Surprisingly, the transport-competent LPH∆4 deletion mutant did not require 
dimerisation of its mannose-rich form in the ER prior to ER egress. As shown in Fig. 
3.2.4 (the second top panel) the mannose-rich form of LPH∆4 persisted as a 
monomeric protein and the complex glycosylated LPH∆4 initially appeared in the 
monomeric fractions. The majority of the complex glycosylated molecules were 
mainly found in the denser gradient fractions. Interestingly, complex glycosylated 
LPH∆4 was revealed in two peaks in the gradient compatible with two quaternary 
states, a dimeric and presumably a tetrameric state. A tetrameric LPH∆4 form would 
be in line with the results obtained by [Panzer et al., 1998] for the LPH1646MACT 
mutant lacking 236 amino acids at the C terminus of homologous domain IV. 
By contrast, LPH∆3 was exclusively detected in the lighter fractions of the gradients 
in its mannose-rich glycoform compatible with retention in the ER as a monomeric 
protein. 
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Fig. 3.2.4: Assessment of the quaternary structure. Transiently transfected COS-1 
cells were biosynthetically labeled and solubilized in 6 mM dodecyl-β-m-maltoside. 
Cell lysates were layered on a sucrose density gradient. After centrifugation for 18h 
at 100,000 x g, fractions were collected, immunoprecipitated and analyzed on SDS-
PAGE. 
 
3.2.3 Transport kinetics of LPH wild type and deletion mutants  
Next, the transport kinetics of the mutants in comparison to wild type LPH were 
analyzed in pulse-chase experiments. Complex glycosylated LPH∆4 appeared within 
1.5 h of chase and its proportion was higher than its counterpart in the wild type 
protein (Fig. 3.2.5, compare also Fig. 3.2.2) indicating that it is more efficiently 
transported to the Golgi apparatus than wild type LPH. By contrast, LPH∆3 persisted 
as a mannose-rich polypeptide compatible with ER localization. Further, the labeling 
intensity of this mannose-rich form of LPH∆3 decreased continuously within 
prolonged chase time points suggesting that this mutant undergoes degradation in 
the ER, presumably by ER-associated degradation (ERAD). The Gly-spacer 
containing LPH∆3-7xGly mutant revealed also similar biosynthetic features as 
LPH∆3 (not shown).  
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Fig. 3.2.5: Transport kinetics of wild type LPH and mutant proteins. Transfected 
COS-1 cells were pulse labeled for 1.5h with [35S]methionine and chased for the 
indicated periods of time with cold methionine. The immunoprecipitates were 
analyzed by SDS-PAGE on 6% slab gels. c, complex glycosylated protein form;  h, 
high mannose or mannose-rich protein form. 
 
3.2.4 Folding of the LPH deletion mutants  
The variations in the quaternary structure of the deletion mutants as well as in their 
transport kinetics raised the question of causal folding variations. Therefore, the 
folding of these mutants was examined by using three procedures. In the first the 
mutants were probed for their protease sensitivity using trypsin, in the second 
procedure the enzymatic activities of the mutants were measured and finally in the 
third reactivity of the mutants with epitope-specific antibodies were assessed. 
 
Trypsin treatment 
The tryptic digestion patterns of the wild type and mutant proteins are depicted in Fig. 
3.2.6. Wild type LPH was digested to two main bands corresponding to cleaved 
mannose-rich and complex glycosylated LPH (cp. Fig. 3.1.5). This pattern did not 
change with prolonged digestion times. Similarly, LPH∆4 pattern was also cleaved to 
two protein products that correspond to the mannose-rich and complex glycosylated 
forms. The smaller apparent molecular weights products fit well with a reduction 
corresponding to the size of the deleted domain IV. In a fashion similar to wild type 
LPH the cleaved products of LPH∆4 were also resistant to trypsin. Importantly, the 
cleavage of LPH∆4 to the final products was not preceded by major intermediate 
cleaved forms suggesting that one major trypsin site is exposed in the deletion 
mutant, which is in all likelihood the same as that in wild type LPH.  
By contrast to wild type LPH and LPH∆4, LPH∆3 was completely degraded by trypsin 
already after 1 min of treatment concomitant with the exposure of several trypsin 
cleavage sites and thus altered folding in comparison to wild type LPH and LPH∆4.  
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Fig. 3.2.6: Trypsin sensitivity assay of wild type and LPH mutants. Transiently 
transfected COS-1 cells were biosynthetically labeled followed by 
immunoprecipitation of LPH proteins from the cell lysates. The immunoprecipitates 
were treated with trypsin for different times and analyzed by SDS-PAGE on 7% slab 
gels. 
 
Enzymatic activities of LPH deletion mutants  
Another approach to examine the folding and maturation pattern of a protein is to 
assess its biological function. Therefore, the enzymatic activities of lactase and 
phlorizin-hydrolase in these mutants in comparison to their wild type counterparts 
were analyzed (Fig. 3.2.7). LPH∆4 revealed slightly reduced activities of phlorizin 
hydrolase. The lactase activity was as expected absent, since the lactase active site 
is found in residue Glu1749 of domain IV. The lactase activity in LPH∆3 was not 
detected. The data provides another support for malfolded LPH∆3 and correct folding 
of LPH∆4. 
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Fig. 3.2.7: Enzymatic activity of deletion mutants (∆-mutants) of LPH. COS-1 
cells were transiently transfected. 48h posttransfection, labeled cells were lysed and 
proteins immunoprecipitated. Immunoprecipitates were incubated with lactose and 
phlorizin, respectively, and the lactase and phlorizin hydrolase activities were 
measured by determining the concentration of released glucose by HPLC. The 
enzyme activities of the mutants were compared with those of wild type LPH. The 
error bar represents standard error. 
 
Epitope mapping of domain deletion mutants 
The deletion mutants were immunoprecipitated with a panel of mAbs, which are 
specific in recognizing native or unfolded conformations of LPH [Naim and Naim, 
1996]. The control samples utilized immunoprecipitation of the GFP-tagged mutants 
with anti-GFP. Fig. 3.2.8 shows that LPH∆4 and LPH∆3 were isolated with anti-GFP 
antibody. Surprisingly none of the mAbs against LPH recognized LPH∆3, even the 
two mAbs, MLac6 and MLac10, that recognize unfolded and denatured forms of LPH. 
LPH∆4, on the other hand, reacted with all the antibodies utilized with the exception 
of MLac6 and MLac10. Given that the antibodies were raised against the mature form 
of LPH, i.e. LPHβ that comprises the two domains III and IV, it is obvious that all 
antibodies except MLac6 and MLac10 possess epitopes in domain III of LPH. Since 
MLac6 and MLac10 are directed against unfolded forms of LPH the results indicate 
that LPH∆4 is properly folded lending a strong support to the protease sensitivity 
data. LPH∆3, on the other hand, is malfolded and is therefore not recognized by the 
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antibodies. It is also likely that none of epitopes is found on LPH∆3. This view is 
supported by the observation that in immunoprecipitation experiments LPH∆3 does 
not react with MLac6 or MLAc10, which are directed against malfolded forms of LPH. 
 
 
Fig. 3.2.8: Epitope mapping of LPH mutants. COS-1 cells were transfected with 
DNA coding for GFP-tagged deletion mutants and biosynthetically labeled 48 h after 
transfection. Cell lysates were divided into equal aliquots and immunoprecipitated 
with anti-GFP and different anti-LPH mAb. The immunoprecipitated proteins were 
analyzed by SDS-PAGE. 
 
3.2.5 Domain III is a transport-competent and functional protein  
The data gathered so far strongly suggest that domain III is a central autonomous 
component of LPH. The next step was therefore to express this domain 
independently and examine its trafficking and functional properties. As shown in Fig. 
3.2.9 domain III expression in COS-1 cells revealed a predominant endo H- and endo 
F-sensitive protein band in the cell lysates indicating that it is a mannose-rich 
glycosylated form of domain III. The cell culture medium contained an endo H-
resistant and endo F-sensitive protein compatible with a complex glycosylated 
domain III. These results clearly indicate that domain III is secreted into the cell 
exterior immediately and rapidly upon maturation in the Golgi apparatus. To 
substantiate the data with a further approach live cell imaging was performed. This 
shows that domain III was located in the ER compatible with the major mannose-rich 
form in the cell lysates. When the cells were subjected to a 20°C temperature block, 
domain III was found in the Golgi apparatus.  
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Fig. 3.2.9: Expression of domain III (D3) in COS-1 cells. A) schematic 
representation of the D3 construct. B) transfected COS-1 cells were biosynthetically 
labeled and proteins were immunoprecipitated from cell lysates and – where 
indicated – from cell culture media. Immunoprecipitates were treated with endo H or 
F, or not treated, analyzed by SDS-PAGE and visualized by autoradiography. C) 
confocal analysis of GFP-tagged D3 in transfected COS-1 cells. ER, endoplasmic 
reticulum; n, nucleus; G, Golgi apparatus. Scale bars, 20 µm. 
 
Assessment of the quaternary structure of domain III – performed at 20°C in order to 
analyze mannose-rich and complex glycosylated proteins – revealed monomeric 
forms of the mannose-rich protein as well as the complex glycosylated form (Fig. 
3.2.10). It should be noted that the overall labeling intensity of the complex 
glycosylated protein in all the lanes as compared to the mannose-rich polypeptide did 
not comprise more than 10% of total domain III in the cell lysates.  
Continuous metabolic labeling was performed to determine the transport rate of 
domain III and domain III appeared in the medium after 90 min of labeling. Finally, 
the folding of domain III was probed utilizing trypsin sensitivity and measurement of 
B 
C 
                                                                                                                           Results 
64 
its enzymatic activity. Fig. 3.2.10 shows that domain III is predominantly resistant to 
trypsin. Its phlorizin hydrolase activity is, however, reduced by about 50%. 
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Fig. 3.2.10: Structural and functional features of domain III (D3). A) assessment 
of the quaternary structure of D3. Transiently transfected COS-1 cells were 
biosynthetically labeled at 20°C to avoid secretion and solubilized in 6 mM dodecyl-β-
m-maltoside. Cell lysates were layered on a sucrose density gradient. After 
centrifugation for 18h at 100,000 x g, fractions were collected, immunoprecipitated 
and analyzed on SDS-PAGE. B) transport kinetics of D3. Biosynthetically labeled 
proteins were immunoprecipitated from cell lysates and cell culture media after the 
indicated labeling times and analyzed by SDS-PAGE. C) trypsin sensitivity assay with 
D3. Transiently transfected COS-1 cells were biosynthetically labeled followed by 
immunoprecipitation of LPH proteins from cell lysates and cell culture media. The 
immunoprecipitates were treated with trypsin for different times and analyzed by 
SDS-PAGE. lys, lysate; med, medium. D) enzymatic activity of domain III (D3). COS-
1 cells were transiently transfected with wild type and D3 cDNA, respectively. 48h 
posttransfection cell lysates and cell culture media were immunoprecipitated with 
anti-LPH mAbs. The immunopreciptitates were incubated with phlorizin and the 
phlorizin-hydrolase activity was measured by determining the concentration of the 
released glucose by HPLC. The enzyme activity of the mutant was compared with 
wild type LPH. The error bar represents standard error. n=4. 
 
3.2.6 Impact of N- and O-glycosylation on the transport of domain III in 
    polarized MDCK cells 
To investigate whether the extensive N- and O-glycosylation of D3 may modulate 
intracellular transport and delivery of D3 to the cell surface, glycosylation inhibitors 
were utilized in combination with immunoprecipitation of cell lysate and cell culture 
media proteins (Fig. 3.2.11). Here, it could be observed that inhibition of N-
glycosylation has not more effect than inhibition of O-glycosylation, and that the ratio 
of intracellular and secreted domain III is similar for treated and untreated cells. 
These results are in line with the data obtained for wild type LPH [Naim and Lentze, 
1992].  
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Fig. 3.2.11: Impact of glycosylation inhibitors on D3 transport. MDCK-II cells 
stably expressing D3 were biosynthetically labeled with [35S]methionine in the 
presence or absence of  modulators of N-glycosylation  (monensin) as well as O-
glycosylation (benzyl-GalNAc). D3 was immunopreciptated from cell lysates and cell 
culture media. The immunoprecipitates were finally analyzed by SDS-PAGE on 9% 
gels and subjected to a phosphorimaging device. 
 
3.2.7 Sorting of domain III in polarized MDCK cells  
LPH is sorted into the apical membrane in polarized MDCK cells and intestinal cells 
with high fidelity. Since it is proposed that putative apical sorting signals are located 
in the ectodomain of the LPH mature form and domain III builds one half of LPHβ, its 
sorting was analyzed in a polarized cell line to determine whether or not this region 
contains putative signals for apical sorting of LPH. Domain III was stably expressed 
in MDCK cells and its sorting was analyzed in a membrane filter system as described 
previously [Jacob et al., 1994]. Fig. 3.2.12 demonstrates that domain III is secreted 
predominantly at the apical surface of MDCK cells. In fact, more than 80% of this 
protein was found at the apical side, indicating that the sorting of domain III is not as 
efficient as for wild type LPH. These data suggest that domain IV is most likely 
devoid of putative apical sorting signals. 
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Fig. 3.2.12: Polarized sorting of domain III (D3). A) MDCK-II cells stably 
expressing D3 were cultured on transwell filters and biosynthetically labeled with 
[35S]methionine. Proteins that have been secreted into the apical and the basolateral 
medium, respectively, were isolated by adding anti-LPH mAb and PAS to the 
collected media. Intracellular proteins were isolated by immunoprecipitation after cell 
lysis. The immunoprecipitates were analyzed by SDS-PAGE on 9% slab gels 
followed by phosphorimaging. B) The quantification of secreted D3 was performed 
with Quantity One® software. The error bars represent standard errors. ic, 
intracellular; ap, apical; bl, basolateral. n=5. 
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3.3 Structural hierarchy of regulatory elements in the folding and
   transport of an intestinal multi-domain protein:  
   Domain I initiates folding of the whole protein while domain 
   II regulates enzymatic activities  
    
Having analyzed so far the roles of homologous domains comprised by mature 
LPHfinal (III and IV), still open questions remain concerning the intramolecular 
organisation and function of the firstly synthesized part of LPH, its profragment 
encompassing domains I and II, or LPHα and the polypeptide stretch Leu735/Arg868 
(=LPHstretch), respectively (cp. Fig. 3.1.1). The presence of LPHstretch within LPHβinitial 
seems to be important during the transport from the ER to the apical plasma 
membrane, at least because it is not removed intracellularly (like the intramolecular 
chaperone LPHα) but at last by luminal trypsin, constituting the final step in LPH 
biosynthesis. Moreover, the fact that the theoretical boundary between homologous 
domains I and II revealed by intramolecular sequence alignment and in silico analysis 
does not correspond to the cleavage site between LPHα and LPHβinitial 
(Arg734/Leu735) [Mantei et al., 1988] suggests that the folding of the LPH profragment 
is not a simple linear process. Therefore, the impact of these homologous domains 
on the generation of a transport-competent configuration of LPH was also addressed 
in conjunction with the question of whether either domain can fold independently. For 
this, several cDNA constructs each lacking the coding region of one homologous 
domain were generated (Fig. 3.3.1). In silico analysis again provided the potential 
domain boundaries as a basis for site-directed loop-out mutagenesis.6 
 
 
Fig. 3.3.1: Schematic presentation of the LPH deletion mutants ∆1 and ∆2. 
 
 
 
 
                                                 
6
 This was done by Julio Polaina, Instituto de Agroquímica y Tecnología de Alimentos, Consejo 
Superior de Investigaciones Científicas, Apdo. de Correos 73, Burjassot, Valencia, E46100, Spain. 
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3.3.1 Expression of wild type pro-LPH and domain deletion mutants in COS-1 
 cells 
To examine the contribution of each of the two homologous domains to the structural, 
functional and trafficking features of LPH, the LPH deletion mutants were expressed 
in COS-1 cells and their characteristics compared to those of wild type LPH (Fig. 
3.3.2). For a better comparability, the wild type data already shown in chapter 3.2 
were displayed again. Cell lysates were immunoprecipitated and the precipitated 
proteins were treated with endo H to determine their glycosylated state as a measure 
of trafficking capacity (Fig. 3.3.2, A and B). LPH∆2 acquired endo H-resistance 
concomitant with complex glycosylation in and trafficking of these mutants to Golgi 
apparatus. By contrast, the mutant lacking homologous domain I, LPH∆1, was not 
transport-competent. Assessment of the proportions of the mannose-rich and 
complex glycosylated forms after scanning of the gels revealed a similar proportion of 
the complex glycosylated LPH∆2 as compared to the wild type counterpart (Fig. 
3.3.2, B). This was surprising, since it indicated that the deletion of the complete 
homologous domain II in LPH∆2 leads to a similar processing of this deletion mutant 
than the wild type protein.  
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Fig. 3.3.2: Glycosylation pattern of LPH wild type and domain deletion mutants 
in COS-1 cells. A) Transiently transfected COS-1 cells were biosynthetically labeled 
for 8h with [35S]methionine followed by immunoprecipitation. The immunoprecipitates 
were divided into two aliquots and treated with endo H, or not treated. The proteins 
were subjected to SDS-PAGE followed by autoradiography. B) densitometric 
scanning of the endo H treated biosynthetic forms of wild type and mutant LPH 
displayed in (A).  
 
The subcellular distribution of the mutant proteins was further investigated in more 
detail by confocal laser microscopy. As shown in Figure 3.3.3, LPH∆1 was retained 
intracellularly and colocalized with the ER-DsRed marker (Fig. 3.3.3, B) and not with 
the Golgi marker (Fig. 3.3.3, C). However, LPH∆2 did colocalize with the ER marker, 
but only little with the Golgi marker and was not detected at the plasma membrane 
(Fig. 3.3.3, B-C), which is in contrast to the biochemical data (cp. Fig. 3.3.2). Since it 
is known that the transport kinetics of LPH-GFP/-YFP is slower than that of untagged 
LPH [Jacob and Naim, 2001], immunofluorescence was performed with COS-1 cells 
expressing untagged LPH∆2. Here, the protein could be detected intracellularly and 
at the cell surface (Fig. 3.3.3, D), suggesting that the presence of a large reporter 
protein within LPH∆2-GFP/-YFP reduces the kinetics beyond a certain threshold 
leading to degradation instead of ER exit.   
 
B 
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Fig. 3.3.3: Subcellular distribution of LPH wild type and domain deletion 
mutants in COS-1 cells. A) confocal analysis of transfected COS-1 cells grown on 
cover slips. B-C) colocalization of LPH mutants with ER and Golgi markers, 
respectively, in transfected COS-1 cells. COS-1 cells were co-transfected with GFP-
tagged LPH proteins and ER-DsRed or YFP-tagged LPH proteins and galactosyl 
transferase (GT)-CFP, respectively. D) immunofluorescence was performed with 
COS-1 cells transfected with LPH∆2 cDNA. Confocal analysis with living cells and 
immunofluorescence were performed 48h after transfection. n, nucleus; arrowheads, 
cell surface; bars, 20 µm. 
 
3.3.2 Requirements for the LPH deletion mutants to exit the ER 
Dimerisation of LPH in the ER is absolutely required for LPH to egress this organelle 
to the Golgi apparatus [Naim and Naim, 1996]. The differential intracellular 
distribution and maturation patterns of the deletion mutants as well as the variable 
proportions of the glycoforms have altogether lead to examine the quaternary 
structures of the mutants and assess their relevance to their transport out of the ER. 
Fig. 3.3.4 depicts the results obtained using sucrose density gradients. As has been 
shown previously (cp. 3.2.2), the dimerisation of the mannose-rich form of LPH 
precedes its complex glycosylation and maturation in the Golgi [Naim and Naim, 
1996]. Surprisingly, the transport-competent LPH∆2 deletion mutant did not require 
dimerisation of its mannose-rich form in the ER prior to ER egress. As shown in Fig. 
3.3.4, A (the second top panel) the mannose-rich form of LPH∆2 persisted as a 
monomeric protein and the complex glycosylated LPH∆2 initially appeared in the 
monomeric fractions. The majority of the complex glycosylated molecules were 
mainly found in the denser gradient fractions. Interestingly, complex glycosylated 
LPH∆2 was revealed in two peaks in the gradient compatible with a monomeric and a 
D 
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dimeric state. By contrast, LPH∆1 was exclusively detected in the lighter fractions of 
the gradients in its mannose-rich glycoform compatible with retention in the ER as a 
monomeric protein. 
 
 
Fig. 3.3.4: Assessment of the quaternary structure. Transiently transfected COS-
1 cells were biosynthetically labeled and solubilized in 6 mM dodecyl-β-m-maltoside. 
Cell lysates were layered on a sucrose density gradient. After centrifugation for 18h 
at 100,000 x g, fractions were collected, immunoprecipitated and analyzed on SDS-
PAGE. 
 
 
3.3.3 Transport kinetics of LPH and deletion mutants 
Next, the transport kinetics of the mutants in comparison to wild type LPH in pulse-
chase experiments was analyzed. Complex glycosylated LPH∆2 appeared within 1.5 
h of chase (Fig. 3.3.5, cp. also Fig. 3.3.2) indicating that it is as efficiently transported 
to the Golgi apparatus as wild type LPH. By contrast, LPH∆1 persisted as a 
mannose-rich polypeptide compatible with ER localization. Further, the labeling 
intensity of this mannose-rich form of LPH∆1 decreased continuously within 
prolonged chase time points suggesting that this mutant undergoes degradation in 
the ER, presumably by ER-associated degradation (ERAD).  
 
                                                                                                                           Results 
74 
 
Fig. 3.3.5: Transport kinetics of wild type LPH and mutant proteins. Transfected 
COS-1 cells were pulse labeled for 1.5h with [35S]methionine and chased for the 
indicated periods of time with cold methionine. The immunoprecipitates were 
analyzed by SDS-PAGE on 6% slab gels.  
 
3.3.4 Folding of the deletion mutants 
The variations in the quaternary structure of the deletion mutants as well as in their 
transport kinetics raised the question of causal folding variations. Therefore, the 
folding of these mutants was examined by using the same procedures described 
above (cp. 3.2.4).  
 
Trypsin treatment 
The tryptic digestion patterns of the wild type and mutant proteins are depicted in Fig. 
3.3.6. Wild type LPH was digested to two main bands corresponding to cleaved 
mannose-rich and complex glycosylated LPH (cp. 3.2.4 and 3.1.5). However, LPH∆2 
pattern was also cleaved to two protein products that correspond to a mannose-rich 
and a complex glycosylated form although both cleavage sites are not present in 
LPH∆2 because they are located within homologous domain II. In a fashion similar to 
wild type LPH the cleaved products of LPH∆2 were also resistant to trypsin. 
Importantly, the cleavage of LPH∆2 to the final products was preceded by major 
intermediate cleaved forms suggesting that several trypsin sites are exposed in the 
deletion mutant, indicating misfolded protein subdomains. Therefore, the cleavage 
products are supposed to contain domain III, which is resistant to trypsin (cp. 3.2.5) 
and which fit well to the smaller apparent molecular weights.  
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By contrast to wild type LPH and LPH∆2, LPH∆1 was completely degraded by trypsin 
already after 1 min of treatment concomitant with the exposure of several trypsin 
cleavage sites and thus altered folding in comparison to wild type LPH and LPH∆2. 
 
 
Fig. 3.3.6: Trypsin sensitivity assay of wild type and LPH mutants. Transiently 
transfected COS-1 cells were biosynthetically labeled followed by 
immunoprecipitation of LPH proteins from the cell lysates. The immunoprecipitates 
were treated with trypsin for different times and analyzed by SDS-PAGE on 7% slab 
gels. 
 
Enzymatic activities of LPH deletion mutants  
In order to assess its biological function, the enzymatic activities of lactase and 
phlorizin-hydrolase in these mutants were analyzed in comparison to their wild type 
counterparts (Fig. 3.3.7). LPH∆2 revealed highly reduced activities of phlorizin 
hydrolase. The lactase activity was absent. Both enzymatic activities in LPH∆1 were 
not detectable. The data provides another support for malfolded LPH∆1 and not 
completely correct folding of LPH∆2. 
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Fig. 3.3.7: Enzymatic activity of deletion mutants (∆-mutants) of LPH. COS-1 
cells were transiently transfected. 48h posttransfection labeled cells were lysed and 
proteins immunoprecipitated. Immunoprecipitates were incubated with lactose and 
phlorizin, respectively, and the lactase and phlorizin hydrolase activities were 
measured by determining the concentration of released glucose by HPLC. The 
enzyme activities of the mutants were compared with those of wild type LPH. 
 
Epitope mapping of domain deletion mutants 
The deletion mutants were immunoprecipitated with a panel of mAbs, which are 
specific in recognizing native or unfolded conformations of LPH [Naim and Naim, 
1996]. The control samples utilized immunoprecipitation of the GFP-tagged mutants 
with anti-GFP. Fig. 3.3.8 shows that LPH∆2 and LPH∆1 were isolated with anti-GFP 
antibody. Interestingly, all of the mAbs against LPH recognized LPH∆1, even the two 
mAbs, MLac6 and MLac10, that recognize unfolded and denatured forms of LPH. 
LPH∆2, on the other hand, reacted well with all the antibodies utilized with the 
exception of MLac6 and MLac10. 
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Fig. 3.3.8: Epitope mapping of LPH mutants. COS-1 cells were transfected with 
DNA coding for GFP-tagged deletion mutants and biosynthetically labeled 48h after 
transfection. Cell lysates were divided into equal aliquots and immunoprecipitated 
with anti-GFP and different anti-LPH mAb. The immunoprecipitated proteins were 
analyzed by SDS-PAGE. 
 
 
3.3.5 Influence of LPHstretch on the transport competence of domain III and 
LPHβ 
The results obtained so far strongly suggest that domain II is not a central 
autonomous component of LPH concerning the attainment of a fully transport-
competent conformation, but crucially influences both enzymatic activities, lactase 
and phlorizin-hydrolase, respectively. The most interesting as well as 
uncharacterized part of homologous domain II constitutes LPHstretch. The next step 
therefore was to express transport competent and enzymatically active proteins 
domain III and LPHβ with and without LPHstretch and examine the trafficking and 
functional properties of all constructs. As shown in Fig. 3.3.9, B, LPHβinitial and 
LPHβfinal expression in COS-1 cells revealed that the presence of LPHstretch hampers 
the transport competence of LPHβ drastically, because no complex glycosylated 
protein form can be detected for LPHβinitial in contrast to LPHβfinal, which displays 
complex glycosylation (see also [Jacob et al., 2002a]). A similar effect of LPHstretch 
could be seen when it is fused to domain III alone. Here, the presence of LPHstretch 
also results in reduced protein transport. However, a small portion of D3stretch is 
secreted into the cell culture medium as N- and O-glycosylated protein forms, 
whereby the N-glycan/O-glycan-ratio seems to be shifted to the O-glycans indicating 
an effect of LPHstretch on glycosylation events. 
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Fig. 3.3.9: Expression of LPHβfinal, LPHβinitial, Domain III and Domain IIIstretch in 
COS-1 cells. A) schematic representation of the LPHβfinal, LPHβinitial, Domain III and 
Domain IIIstretch constructs. B-C) COS-1 cells were biosynthetically labeled 48h 
posttransfection. Proteins were immunoprecipitated from cell lysates and - where 
indicated - from cell culture media, treated with endo H or F, or not treated, analyzed 
by SDS-PAGE and visualized by autoradiography. 
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3.3.6 Association of domain III with other extracellullar LPH domains 
reduces its  transport competence 
In order to investigate the role of LPHstretch during LPH biosynthesis in more detail 
constructs were generated, which contain domain III – the autonomously folded core 
domain (cp. 3.2.5) – as well as LPHstretch and other LPH domains. 
Interestingly, as shown by Fig. 3.3.10, B, the construct comprising LPHα, LPHstretch 
and domain III (denoted D123) is efficiently transported and secreted into the cell 
culture medium as endo H-resistant and endo F-sensitive protein similar as domain 
III (cp. 3.2.5 and 3.3.5). However, the protein composed of the complete LPH 
ectodomain (see also [Naim and Naim, 1996]) as well as the protein consisting of 
homologous domains II and III do not attain transport competent conformations and 
are retained in the ER.    
 
 
 
  
Fig. 3.3.10: Expression of homologous Domain III-containing LPH regions in 
COS-1 cells. A) schematic representation of the, Domain I-II-III, Domain I-II-III-IV, 
Domain II-III constructs. B) COS-1 cells were biosynthetically labeled 48h 
posttransfection. Proteins were immunoprecipitated from cell lysates and - where 
indicated - from cell culture media, treated with endo H or F, or not treated, analyzed 
by SDS-PAGE and visualized by autoradiography. 
A 
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3.3.7 Expression of profragment subdomains reveals non-transport-
 competent proteins 
The analysis of the role of LPHstretch on LPH biosynthesis and function so far revealed 
that LPHstretch containing proteins are only transport competent when i) domain III is 
present, ii) domain IV is absent, and iii) LPHα is completely present or absent and not 
in part, presumably because LPHα can positively act as intramolecular chaperone 
only as a whole. 
In order to further elucidate the interactions and the structural hierarchy of LPHα and 
LPHstretch, or homologous domains I and II, respectively, constructs containing parts 
of the LPH profragment were generated and expressed in COS cells (Fig. 3.3.11). 
pAb V496 binds the first part of homologous domain I and could therefore be used for 
immunoprecipitation of domain I, LPHα and the profragment (denoted D12). Domain 
II was fused to a FLAG-tag und isolated with mAb anti-FLAG. The results revealed 
that none of them attains transport competence and that all are retained in the ER.   
 
 
  
A 
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Fig. 3.3.11: Expression of LPH profragment domains in COS-1 cells. A) 
schematic representation of the LPHα, Domain I-II, Domain II3xFLAG and Domain I 
constructs. B) transiently transfected COS-1 cells were biosynthetically labeled 48h 
posttransfection. Proteins were immunoprecipitated from cell lysates and cell culture 
media with pAb V496 or anti-FLAG antibodies, respectively, treated with endo H or F, 
or not treated, analyzed by SDS-PAGE and visualized by autoradiography. 
Arrowheads indicate unspecific protein bands.  
 
 
B 
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3.4  Elimination of a homologous domain of an intestinal  
    hydrolase results in changed intracellular trafficking via 
    altered membrane association  
 
The results gathered so far shed light on pathobiochemical mechanisms of CLD by 
characterizing a distinct mutation (cp. 3.1) as well as on the intramolecular 
organisation of the LPH protein by loop-out mutagenesis and construction of deletion 
or individual domain forms (cp. 3.2 and 3.3). Further experiments were planned and 
performed, in order to reveal LPH-related biochemical and physiological 
mechanisms. Here, LPH – besides other model proteins – is used as an experimental 
tool to elucidate general biochemical, physiological and cell biological mechanisms. 
 
3.4.1 LPH∆4’s intracellular transport differs from that of wild type LPH and SI 
Jacob and Naim could clearly show by confocal laser microscopy that LPH and 
another intestinal brush border membrane hydrolase, sucrase-isomaltase (SI), are 
transported from the Golgi apparatus to the cell surface in the same transport 
vesicles [Jacob and Naim, 2001]. In these vesicles areas could be detected, in which 
only SI is located in distinct clusters, whereas LPH is equally distributed over the 
vesicle surface. After both enzymes have passed the trans-Golgi network (TGN), 
they are distributed to separate vesicles [Jacob and Naim, 2001]. Subsequent 
experiments displayed that these different vesicles – denoted SI- and LPH-carrying 
apical vesicles (SAVs and LAVs), respectively – are transported with their divergent 
cargo by different cytoscelettal structures [Jacob et al., 2003]. In order to find out if 
the deletion of homologous domain IV has an effect on LPH trafficking in more detail, 
COS-1 cells grown on cover slips were co-transfected with cDNAs coding for 
fluorescence-tagged LPH∆4 and wild type LPH or SI, respectively (Fig. 3.4.1). 
Interestingly, LPH∆4 was predominantly found in vesicular structures and not in the 
Golgi apparatus, whereas the subcellular localization of LPH was vice versa when 
coexpressed in COS-1 cells and analysed after 4 h at 20°C followed by 20 min at 
37°C (Fig. 3.4.1, A). Furthermore, LPH could be found in the same vesicles as 
LPH∆4, but almost no colocalization was detectable within these vesicles (shown in 
white). When SI and LPH∆4 were coexpressed, SI was also found in the Golgi and in 
vesicles like LPH (Fig. 3.4.1, B), but in contrast, LPH∆4 and SI did colocalize 
moreoften within these vesicles (shown in yellow). The 20°C block and the 37°C 
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chase were performed in the presence of cycloheximide to eliminate background 
fluorescence by inhibition of protein synthesis. 
 
          
Fig. 3.4.1: Colocalization of LPH∆4 with wild type LPH and sucrase-isomaltase. 
LPH∆4 colocalizes partly with wild type LPH but not with sucrase-isomaltase (SI). 
COS-1 cells were cotransfected with LPH-YFP and LPH∆4-CFP (A) or SI-cherry and 
∆4-GFP (B). 36h posttransfection, the cells were incubated for 4h at 20°C to 
accumulate proteins in the Golgi apparatus. This incubation was performed in the 
presence of 1.6 mM cycloheximide to inhibit protein synthesis. After the block, the 
cells were incubated at 37°C for 20 min to chase the proteins out of the TGN, fixed 
and analyzed by confocal microscopy. Bars, 20 µm. 
 
3.4.2 LPH∆4 associates differently with detergent resistant membranes  
Both apically sorted hydrolases, LPH and SI, are associated with the membrane via 
transmembrane protein domains. However, SI is located in Triton X-100-resistant, 
sphingolipid/cholesterol-enriched membrane microdomains or lipid rafts, while LPH is 
not [Jacob and Naim, 2001]. Lipid rafts are supposed to be sorting platforms [Alfalah 
et al., 2005; Lindner and Naim, 2009; Simons and Ikonen, 1997] and LPH∆4 
displayed different trafficking characteristics than wild type LPH and SI. Therefore, 
the next experimental step was to investigate, how the lack of homologous domain IV 
– which is in closest vicinity to the membrane in contrast to the rest of the LPH 
ectodomain (cp. Fig. 3.1.1) – effects the association of LPH∆4 with different kinds of 
detergent resistant membranes in comparison to wild type LPH. In order to have 
comparable experimental conditions as in the colocalization study described above, 
cells were transfected with cDNAs coding for fluorescence-tagged SI, LPH and 
LPH∆4 proteins. 
 
 
A B 
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3.4.2.1  Triton X-100-resistant membranes  
The detergent used to isolate ‘classical’ rafts is Triton X-100 [Brown and Rose, 1992; 
Simons and Ikonen, 1997], therefore LPH∆4 membrane association was analyzed by 
isolating Triton X-100-resistant membranes. SI showed the known pattern of 
membrane association in pelletation experiments, i.e. the complex glycosylated 
protein form could be isolated from the pellet, while the mannose-rich glycosylated 
portion was not [Alfalah et al., 1999]. However, although LPH was mainly found in the 
supernatant, a clear portion of complex as well as mannose-rich glycosylated protein 
was also found in the pellet, which is in contradiction to the published data [Jacob 
and Naim, 2001]. A contamination of the DRM fraction with non-DRM material can be 
excluded because of the control (SI) and the fact that a low-speed centrifugation step 
was performed before ultracentrifugation (cp. 2.2.4, Extraction of detergent resistant 
lipid microdomains). In order to further exclude artificial DRM-association, floating 
experiments should be performed. LPH∆4 also showed a weak association with 
Triton X-100-resistant membranes.  
 
 
Fig. 3.4.2: Association of LPH∆4 with Triton X-100-resistant membranes. 
Metabolic labeling of transfected COS-1 cells was performed for the indicated times, 
followed by solubilization in ice-cold Triton X-100. Proteins were immunoprecipitated 
from the detergent-soluble (s) and from the detergent-insoluble pellet (p) fractions. 
 
3.4.2.2  Lubrol WX-resistant membranes 
Lipids and proteins as main components of membranes are the basis for the 
heterogenous structures of cellular organelles [Sprong et al., 2001] and membrane 
subdomains [Roper et al., 2000], whereby the heterogeneity of the latter does not 
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only depend on selective lipid and protein enrichment, but also on their locations and 
functions. Based on this, it is likely that membrane-bound proteins associate with 
different kinds of membranes on their route to the final destination.  
Many proteins, which are completely soluble in Triton X-100, show a certain 
insolubility in other mild detergents [Drevot et al., 2002; Holm et al., 2003; Roper et 
al., 2000]. Additionally, the membrane microdomains isolated with these detergents 
reveal differences in protein and lipid constitution [Schuck et al., 2003]. Castelletti et 
al. could show that the prostate-specific membrane antigen (PSMA) is detectable in 
two different kinds of detergent-resistant membranes [Castelletti et al., 2008]. Here, 
its biosynthetic forms associate with membrane microdomains of different constitution 
and suggest a role of compartment-specific detergent-resistant membranes in protein 
transport. 
In order to investigate, if the results obtained for PSMA are reproducible for LPH and 
if the difference between LPH and LPH∆4 in trafficking is due to an altered 
association with Lubrol-DRMs, pelletation experiments with Lubrol WX were 
performed (Fig. 3.4.3). Continous metabolic labeling revealed that both wild type LPH 
protein glycoforms – mannose-rich and complex glycosylated – are predominantly 
found in the DRMs (Fig. 3.4.3, A). However, complex glycosylated LPH∆4 is mainly 
found in the DRMs, whereas the mannose-rich glycoform is mainly soluble. For the 
analysis of early trafficking protein-membrane interaction dynamics a pulse-chase 
protocol was followed (Fig. 3.4.3, B). 
The data obtained so far suggest for both proteins – wild type and LPH∆4 – that the 
mannose-rich protein form (which appears first) is predominantly soluble in Lubrol 
WX. Subsequently, this glycoform could also be detected in DRMs. Then, the 
complex glycosylated protein form appears first in the soluble fraction, before its 
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Fig. 3.4.3: Association of LPH∆4 with Lubrol WX-resistant membranes. 
Metabolic  labeling of transfected COS-1 cells was performed continuously (A) or 
following a pulse-chase protocol (B) with 1h pulse (upper panel) and 30 min pulse 
(lower panel), respectively, followed by the indicated chase times and solubilization in 
ice-cold Lubrol. Proteins were immunoprecipitated from the detergent-soluble (s) and 
detergent-insoluble pellet (p) fractions.  
 
3.4.2.3  Tween 20-resistant membranes 
Another mild non-ionic detergent utilzed in the investigations concerning protein 
transport, trafficking and sorting constitutes Tween 20. It was found to entirely 
solubilze basolateral but not apically sorted membrane proteins indicating protein 
sorting events at the stage of the ER [Alfalah et al., 2005]. Moreover, Tween 20-
resistant membranes seem to be involved in early trafficking control mechanisms 
between the ER and the cis-Golgi apparatus [Hein et al., 2009].  
B 
A 
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Since LPH wild type and LPH∆4 differences are mainly found in the early secretory 
pathway – e.g. ER-Golgi transport kinetics (cp. 3.2.3) and quaternary structure (cp. 
3.2.2) – the association with Tween 20-resistant membranes was analyzed (Fig. 
3.4.4). Biosynthetic labeling following a pulse-chase protocol revealed that mannose-
rich protein forms of SI, LPH and LPH∆4 are predominantely associated with DRMs 
after 1 h of labeling (Fig. 3.4.4, A). After 5 h of labeling, complex and mannose-rich 
glycosylated SI were mainly found in the pellet, whereas a large portion of mannose-
rich LPH and LPH∆4 could be detected in the soluble fraction and – in contrast to SI 
– the complex form was mainly found in the soluble fraction after 5 h chase. 
Surprisingly, almost no more mannose-rich LPH∆4 was found to be associated with 
DRMs. 
To further elucidate the mechanisms underlying early protein trafficking and its 
connection with intracellular membrane diversity and heterogeneity, the association 
with Tween 20-DRMs was investigated at 15°C, a temperature which blocks protein 
transport between the ER and cis-Golgi [Tomas et al., 2010]. Again, LPH∆4 was less 
associated with DRMs than SI and LPH. Additionally, the soluble portion of LPH∆4 
was clearly smaller than its counterpart of the the DRM fraction, indicating a 
difference in glycosylation. This observed distribution of the investigated proteins 
could also be found, when the cells were treated with brefeldin A (BFA) during 
metabolic labeling, a drug known to inhibit retrograde protein transport from the Golgi 
leading to accumulation of proteins in the ER [Nebenfuhr et al., 2002], confirming the 
difference in membrane association between wild type LPH and LPH∆4 in the early 
trafficking pathway.   
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Fig. 3.4.4: Association of LPH∆4 with Tween 20-resistant membranes. Metabolic  
labeling of transfected COS-1 cells was performed following a pulse-chase protocol 
at 37°C (A) or continuously at 37°C and 15°C (upper panel) or at 37°C in the 
presence of BFA (lower panel), respectively (B) followed by solubilization in ice-cold 
Tween 20. Proteins were immunoprecipitated from the detergent-soluble (s) and 
detergent-insoluble pellet (p) fractions. 
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4.  Discussion   
 
4.1  Impaired trafficking and subcellular localization of a mutant 
  lactase associated with congenital lactase deficiency 
 
Carbohydrate malabsorption associated with brush border LPH occurs in two forms, 
adult-type hypolactasia and congenital lactase deficiency or alactasia. Adult-type 
hypolactasia is mainly linked to a DNA variant, C/T-13910, about 14 kb upstream 
from the gene locus of LPH and also to another variant, G/A-22018, 8 kb telomeric to 
C/T-13910, both of which are associated with low lactase digesting capacity [Enattah 
et al., 2002],. Congenital lactase deficiency, on the other hand, is a more severe and 
life-threatening form of lactose malabsorption in the newborn, where milk is the only 
food. While the symptoms of adult-type hypolactasia increase with age and many 
patients develop signs of lactose intolerance in adolescence and adulthood, the 
typical symptoms of CLD start a few days after birth with the onset of breast (or 
lactose-containing formula) feeding. They consist of liquid and acid diarrhea, 
meteorism, and severe malnutrition. Until very recently the genetic background of 
CLD has been completely unknown. Genetic analysis of several Finnish families has 
unraveled multiple mutations in the coding region of the lactase gene that are 
associated with CLD [Kuokkanen et al., 2006; Torniainen et al., 2009]. Strikingly, 
84% of the patients were homozygous for a nonsense mutation, c.4170T-->A 
(Y1390X). This stop codon would generate a translated product of LPH from which 
the entire homologous domain IV that contains the lactase active site, Glu1749, has 
been truncated. Obviously this deletion mutant is enzymatically inactive and therefore 
triggers the onset of lactose malabsorption. 
The G1363S mutation, on the other hand, does not affect the length of the translation 
LPH product and has been therefore investigated further at the protein and cellular 
levels. As shown here substantial alterations in the posttranslational processing and 
maturation of LPH are elicited by this mutation. Interestingly the mutation occurs in a 
region that is highly conserved in different species (cp. Table 3.1.1) and additionally 
generates a potential N-glycosylation site suggesting that the Gly1363 residue plays an 
essential role in the context of folding of the homologous domain III in particular and 
the LPH in general. While N-glycosylation per se is required for correct folding and 
dimerisation of LPH, additional N-glycosylation in domain IV in the immediate 
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proximity of the membrane anchor sterically hinders the generation of stable dimeric 
LPH forms and reduces substantially the trafficking rates of LPH from the ER to the 
Golgi apparatus [Jacob et al., 2000]. While the data presented here reveal an 
increased N-glycosylation of mutant LPH-G1363S, this additional glycosylation site is 
not immediately implicated in the pathogenesis of the CLD phenotype. In fact, 
elimination of this site in the LPH-N1361A/G1363S mutant reveals similar 
biosynthetic, structural and functional features to LPH-G1363S. Remarkably, LPH-
G1363S reveals the characteristics of a temperature-sensitive mutant that acquires 
partial transport-competence and is capable to exit the ER at a permissive 
temperature of 20°C. The partial transport-competence is paralleled by an increase in 
the enzymatic activity of lactase, but not by the acquisition of trypsin-resistance and 
hence wild type-like folding determinants. It appears that at this reduced temperature 
subdomains of the LPH protein implicated in the enzymatic activity acquire partial 
folding and hence partial enzymatic activity.  
 
Temperature-sensitive and trafficking-impaired mutants of glycoproteins are 
associated with the pathogenesis of disease. Examples of these mutant proteins are 
sucrase-isomaltase phenotype II (SI-Q1098P) in congenital sucrase-isomaltase 
deficiency [Propsting et al., 2005], the DeltaF508 mutant of the cystic fibrosis 
transmembrane conductance regulator in cystic fibrosis [van Barneveld et al., 2006], 
the NPC1(I1061T) mutation in Niemann-Pick type C1 disease [Gelsthorpe et al., 
2008] or the bile salt export pump in progressive familial intrahepatic cholestasis type 
2 [Plass et al., 2004].  
These mutants can exit the ER at the permissive temperature and are able to recycle 
between the ER and the cis-Golgi bypassing thus the ER quality control machinery 
[Propsting et al., 2005]. Another feature of these mutants is their sensitivity towards 
chemical chaperones that facilitate correct folding and subsequent acquisition of 
functional properties. Chemical chaperones are small cell- and ER-permeable 
molecules, which stabilize the native folding status of proteins within the ER [Ulloa-
Aguirre et al., 2004] with the potential of altering the folding of mutant proteins, thus 
weakening distinct diseases that are caused by such misfolded protein mutants. One 
chemical chaperone is curcumin (1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione), the yellow main substance of the spice curcuma, isolated 
from Curcuma longa. It shows anti-inflammatorial, anti-oxidative and anti-proliferative 
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features [Ammon and Wahl, 1991; Salvioli et al., 2007]. Another chemical chaperone 
is cyclosporin A, which constitutes an unpolar, cyclic oligopeptide and metabolite of 
the fungus Tolypocladium inflatum. It has strong immunosuppressive characteristics 
and influences T-lymphocytes [Borel et al., 1976] by inhibiting nuclear proteins 
related to T-cell activation [Emmel et al., 1989]. Chemical chaperoning is utilized in 
diseases like Chorea Huntington [Dikshit et al., 2006] and Cystic Fibrosis [Egan et al., 
2004; Harada et al., 2007]. Exposure of the DeltaF508 of the cystic fibrosis 
transmembrane conductance regulator to curcumin [Egan et al., 2004] or to small 
chemical chaperones, such as osmolytes glycerol and trimethylamine N-oxide 
[Fischer et al., 2001; Zhang et al., 2003], rescue the folding defect of this mutant and 
restore partially its activity. It is tempting to propose that the temperature-sensitive 
LPH-G1363S mutant may behave in a similar fashion towards this type of 
chaperones.    
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4.2  Structural hierarchy of regulatory elements in the folding and transport of 
   an intestinal multi-domain protein:  
   Domain III constitutes the structural core while domain IV has a 
 regulatory role 
 
Characterization of the structure, biosynthesis and trafficking of the individual 
subdomains within pro-LPH, an essential brush border membrane enzyme, 
constitutes an important step towards understanding its function and impact to the 
intestinal epithelial cell physiology. Given that the three-dimensional structure of LPH 
has not been elucidated yet, alternative approaches have to be designed to 
determine the significance and relevance of the individual subunits to each other in 
the context of this multiple domain protein. 
Lactases, or more properly, ß-galactosidases, are grouped within 4 of the near 100 
families of glycosyl hydrolases (GHs) that have been characterized [Coutinho and 
Henrissat, 1999]. Mammalian intestinal lactase (LPH) is classified in the GH1 family, 
along with enzymes present in a variety of organisms acting against different types of 
ß-glycosides. While most GH1 enzymes (mostly bacterial) thus far characterized are 
conformed by a single domain, intestinal lactase is synthesized as a multidomain 
precursor protein that is encoded by a gene resulting from the fusion of 4 tandemly-
arranged repetitions of an ancestor gene [Mantei et al., 1988; Naim et al., 1991]. 
Maturation of the enzyme generates the brush border form comprized by the last 2 
domains, III and IV [Jacob et al., 2002a] each with differential activity. Domain III 
shows specificity towards glycosides, such as phlorizin, while domain IV is 
specifically active against lactose [Arribas et al., 2000]. Interestingly, individual 
expression of domain III of LPH reveals a correctly folded, transport-competent and 
rapidly secreted molecule underscoring thus its autonomous character that has been 
conserved from prokaryotes to eukaryotes. 
Despite its strong homologies with domain III, domain IV is not a folding-competent, 
transport-competent or an enzymatically active species per se. This domain, 
however, plays a central regulatory role in the context of the function and trafficking 
of LPH. It contains the LAC236 stretch that is required for dimerisation of LPH [Jacob 
et al., 2000; Panzer et al., 1998]. The essential function of domain IV within the LPH 
complex becomes evident when considering its role in the dimerisation of LPH. In 
fact, domain III does not dimerise and the phlorizin-hydrolase activity of this domain 
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is elevated by a factor of 2.5 fold in the dimeric LPH molecule. Additionally, domain 
IV is rate-limiting along the secretory pathway of LPH from the ER to the Golgi. In 
fact, LPH∆4, a deletion mutant that lacks the entire homologous domain IV, acquires 
more rapidly complex glycosylation than its wild type counterpart proposing a role of 
this domain in decelerating LPH processing. Importantly, LPH∆4 does not dimerise in 
the ER lending a strong support to the view that dimerisation is initiated by 
homologous domain IV and supporting previous data that assigned a role of LAC236 
an essential role in dimerisation. It is very likely therefore that the retarded trafficking 
of wild type LPH in comparison to LPH∆4 is due to its dimerisation prior to the ER 
exit, while this additional step is not required for LPH∆4 to acquire transport-
competence. Interestingly, epitope mapping with a panel of mAbs against the mature 
brush border form of LPH (domains III and IV) demonstrated a similar pattern of 
recognition for LPH∆4 and LPH strongly suggesting that the epitopes tested are 
located in domain III. Given that these antibodies (except MLac6 and MLac10) react 
only with native LPH species, but not with denatured LPH the data strongly suggest 
that the tertiary structure of LPH∆4 is comparable with its counterparts in human wild 
type LPH and that domain III represents the structural core of the mature protein.  
On the other hand, domain IV is not an autonomous region. It harbours the lactase 
catalytic site at Glu1749 [Arribas et al., 2000; Zecca et al., 1998] and acquires activity 
only when LPH dimerises [Naim and Naim, 1996]. Domain IV plays therefore a role 
as a regulatory switch that triggers the dimerisation of the LPH molecule thus 
activating itself and elevating the phlorizin hydrolase activities in domain III.  
Concerning of the correctness of the chosen domain boundaries, the question can 
arise, how it can be ruled out that the reason for the negative results regarding 
deletion of homologous domain III is just that domain boundaries might extend 
beyond the deleted fragment. Here, the possibility exists that the evolutionary related 
domains have evolved into intertwined folds that can hardly be disentagled by simple 
deletions.  However, in this case in which structural information about related proteins 
is abundant – as well as in other domain-shuffling strategies – the problem is not so 
much defining the limits of the domains as it is to sort out possible interactions 
between domains that have coevolved as parts of a single polypeptide. As an 
indication that the domain boundaries were defined correctly and that domain III, 
even in the absence of domain IV, it is able to fold properly into a viable structure 
serves in any case the fact that the LPH construction lacking domain IV retains 
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substantial phlorizin hydrolase activity. Moreover, it shows that the structural 
determinants of dimerisation are totally, or at least partially, outside domain III. For 
sure, one has to be more cautious in the interpretation of negative results, but the 
results of this work support the conclusion that domain IV requires of domain III to 
develop a stable conformation. It is likely therefore that the mutation G1363S within 
domain III has induced conformational changes in homologous domain IV that 
harbors the lactase activity. 
The data present a hierarchical model of LPH in which the homologous domain III 
constitutes a fully autonomous core domain within the LPH molecule. In addition it 
represents another intramolecular chaperone of LPH besides the profragment LPHα 
(Fig. 4.2.1). This model assumes that the profragment [Jacob et al., 2002a] and 
homologous domain III (the data presented here) attain their native conformation 
autonomously. While domain III is transport-competent and enzymatically active per 
se, it requires homologous domain IV for elevation of its enzymatic activity and 
regulation of its trafficking kinetics. This occurs via dimerisation of the entire LPH 
molecule, an event that is triggered by domain IV. Nevertheless, domain IV is a non-
autonmous domain that can not fold independently; it requires the profragment as 
well as domain III as templates for correct folding. Correctly folded domain IV is now 
capable of triggering the dimerisation of LPH in the ER [Naim and Naim, 1996], an 
event that is required for LPH to exit the ER, for regulation of its transport kinetics 
and elevation of its enzymatic activities. The profragment and domain III function 
therefore as switches for correct folding of domain IV, which in turn “pays back” by 
giving domain III an increased phlorizin-hydrolase activity and gaining more activity 
as the lactase active site. 
To my knowledge, this is the first example of a mechanism, in which a protein has 
two intramolecular chaperones and is not activated by propeptide cleavage like 
described for zymogens, neuropeptides, and prohormones [Barr, 1991; Steiner et al., 
1984], but by intramolecular organisation and oligomerisation. 
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Fig. 4.2.1: Hierarchy model of LPH biosynthesis in the ER. The LPH precursor is 
synthesized at the ER and translocated in the ER lumen starting with the 
independently folding N-terminal profragment (A). Subsequently, autonomous 
domain III is synthesized and acquires correct folding independent of other domains 
(B), while homologous domain IV that associates LPH with the membrane is not 
capable of folding independently (C) and requires the profragment and domain III as 
folding templates (D). Finally, the correctly folded monomer LPH interacts with 
another monomer via the correctly folded domain IV to form a transport-competent 
LPH dimer that exits the ER and acquires full lactase and phlorizin hydrolase 
activities (E).  
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4.3 Structural hierarchy of regulatory elements in the folding and transport of 
   an intestinal multi-domain protein: 
  Domain I initiates folding of the whole protein while domain II regulates
  enzymatic activities  
 
Many proteins comprise specific sequences, which are important for folding 
processes but not for protein function directly. They act as intramolecular chaperones 
and are eliminated in post-translational modification events [Chen and Inouye, 2008]. 
LPH contains an N-terminally located propeptide, which is almost as large as the 
mature protein [Naim et al., 1994]. For the major part of this profragment, LPHα, it 
could be shown that it acts as an intramolecular chaperone [Jacob et al., 2002a], but 
the role of the minor part, LPHstretch, needs to be further elucidated. Moreover, the 
exact intramolecular organisation of LPH is a complex process, since i) homologous 
domain III constitutes the second intramolecular chaperone, ii) domain IV is 
supposed to have a regulatory function (cp. 3.2), and iii) the membrane anchor 
together with the cytoplasmic tail are also important for the attainment of a transport-
competent conformation [Naim and Naim, 1996]. Additionally, recent findings of a first 
structural and dynamics study of a nascent protein support the hypothesis that a 
native tertiary structure of a polypeptide chain can be reached already on the 
ribosome [Hsu et al., 2007]. Therefore, the elucidation of early events in the 
biosynthesis of the nascent LPH polypeptide is of great interest for the understanding 
of the intramolecular organisation of multi-domain membrane-anchored proteins in 
general.  
The absence of homologous domain II as part of the profragment including the 
polypeptide stretch Leu735-Arg868 (LPHstretch) results in a protein with a transport 
competence comparable to the wild type protein, therefore homologous domain II 
could be a slow folding domain like domain IV which decelerates LPH processing 
maybe by interacting with other proteins likely within the ER. Domain III and domain 
IV are the mainly glycosylated regions (each domain contains five potential N-
glycosylation sites, whereas domains I and II contain two and three sites, 
respectively). That is why for LPH∆2 - like for wild type LPH - the mannose-rich and 
the complex glycosylated protein forms are clearly distinguishable without endo H 
treatment, but not for LPH∆4, because here the highly glycosylated domain IV is 
absent (cp. Fig. 3.2.2 and Fig. 3.3.2). The LPH∆1 protein - lacking homologous 
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domain I, which is completely included within the intramolecular chaperone LPHα - is 
not transport competent and - like domain III - domain I seems to be also structurally 
important for the whole protein facilitating ER export and more important for the 
chaperone function than the first part of homologous domain II. 
LPH∆2 dimerises, but in the Golgi apparatus and not in the ER like wild type LPH. 
Like LPH∆4 it seems to be involved in the oligomerisation process, but in contrast to 
LPH∆4 it does not form higher oligomers and therefore domain II is not supposed to 
stabilize dimeric forms. Finally, domain I seems to be also important for LPH 
quaternary structure, since LPH∆1 does not dimerise. This influence can be directly 
by facilitating dimerisation or indirectly by influencing other LPH regions by its 
chaperone effect. 
The analysis of the LPH∆-mutant transport kinetics revealed that indeed LPH∆1 is 
not transport competent and what is more is degraded, because the band intensities 
of the mannose-rich forms decrease with time. Transport kinetics of LPH∆2 is slower 
than for the wild type, but its mannose-rich protein form seems to be stable and 
converted to the complex glycosylated form and not degraded like for LPH∆1. 
Therefore, domain II - as part of the intramolecular chaperone LPHα - is not a slow 
folding domain but supports folding of other LPH regions. 
The protease sensitivity assay with trypsin shows that LPH∆1 is degraded and 
therefore badly folded, because more potential trypsin cleavage sites are exposed. 
Moreover, LPH∆2 is also reduced in size to two trypsin resistant protein forms like 
wild type LPH and LPH∆4, but this reduction occurs over intermediate forms. One 
reason for this is most likely that the two cleavage sites exposed in wild type (cp. Fig. 
3.2.1) are absent because domain II is deleted. Another reason is that LPH∆2 seems 
not to be folded properly, because the resulting bands have a size comparable to the 
cleavage products of LPH∆4 and not of wild type, although LPH∆2 incorporates 
LPHβfinal like LPH wild type. Therefore, the presence of domain II, encompassing a 
part of LPHα and the polypetide stretch between the protease cleavage sites, seems 
to be crucial for the correct folding of the other domains and the whole protein. 
The analyses of the enzymatic activity of the LPH∆-mutants revealed that only 
LPH∆4 and to a lesser extend LPH∆2 show phlorizin-hydrolase activity, from which 
can be concluded that all LPH domains are crucial for the attainment of a correct 
lactase and phlorizin-hydrolase activity subdomain conformation except domain IV.  
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During the epitope mapping all of the antibodies reacted with all mutants except 
LPH∆3 (cp. 3.2.4 and 3.3.4, Epitope mapping of domain deletion mutants). The 
antibodies tested were all raised against mature LPH, and it is likely therefore that 
conformation-specific antibodies are among those used. The results strongly suggest 
that the LPH epitopes tested were present or were not substantially modified in the 
mutants LPH∆4, LPH∆2 and LPH∆1 as compared with wild type LPH, and that 
therefore all epitopes are localized in domain III.  
Initial cleavage of mature pro-LPH in the Golgi occurs between Arg734 and Leu735 and 
generates LPHβinitial that is transported with high fidelity to the apical membrane. In 
the intestinal lumen LPHβinitial undergoes another cleavage at Arg868/Ala869 by 
pancreatic trypsin to generate LPHβfinal [Jacob et al., 1996; Wuthrich et al., 1996]. 
The significance of the stretch between Leu735 and Arg868 in the context of trafficking 
and sorting of LPH has been until present obscure. The data presented here assign a 
role to this region (in association with domain III) in the sorting of LPH to the apical 
membrane. It is interesting to note that domain III per se is not as efficiently 
transported to the apical membrane in polarized MDCK cells as wild type LPH 
strongly proposing that the polypeptide stretch Leu735-Arg868 in domain II could be 
important for the fine-tuning of polarized sorting.  
Another reason, why LPHstretch is not already eliminated intracellularly like LPHα, but 
at the cell surface by luminal trypsin is its implication in the formation of an 
enzymatically active conformation. This hypothesis is supported by the observation 
that LPH∆2 – which lacks LPHstretch – is transport competent but almost completely 
devoid of enzymatic activity. Moreover, LPH∆2 is cleaved to two small protein forms 
by trypsin, although it lacks both trypsin cleavage sites exposed in wild type LPH, 
indicating that the lack of domain II does not result in a properly folded protein. 
Furthermore, LPHstretch is not capable to attain a transport competent conformation 
autonomously, because its presence reduces transport competence of domain III and 
prohibits ER exit of LPHβ. However, the presence of LPHstretch together with LPHα in 
D123 does not inhibit ER exit, indicating that the intramolecular chaperone LPHα 
counteracts the slow-folding effect of LPHstretch. Interestingly, the presence of only a 
part of LPHα in D23 and LPH∆1 is not sufficient to attain transport competence. 
Additionally, the presence of LPHα, LPHstretch as well as domain III and domain IV is 
also not enough to exit the ER, if the membrane anchor and the cytosolic tail are 
absent like in D1234 [Naim and Naim, 1996]. 
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In order to further unravel the spatiotemporal hierarchy and the structural-functional 
correlation of LPH intramolecular organisation events, more comparative analyses 
have to be performed, e.g. on the sorting of efficiency LPH∆2, domain IIIstretch and 
D123 as well as on enzymatic activities of all constructs containing phlorizin 
hydrolase, i.e. D123, D23, LPHβinitial, LPHβfinal, domain IIIstretch and domain III. Finally, 
it will be inevitable to investigate the structure of LPH directly by cristallization 
studies, for which the transport competent proteins domain IIIstretch, domain III and 
D123 constitute the appropriate constructs, because these are soluble and do not 
have hydrophobic regions. 
 
The group of protein profragments can be classified into two subgroups, based upon 
their different ways of acting as an intramolecular chaperone [Chen and Inouye, 
2008]. Type I intramolecular chaperones are mostly N-terminally located and support 
the formation of tertiary structures, like described for α-lytic protease [Anderson et al., 
1999], nerve growth factor (NGF) [Kliemannel et al., 2004], and proinsulin [Munte et 
al., 2005]. Type II intramolecular chaperones are mainly found at the C-terminus and 
do not influence the formation of tertiary structures, but support the assembly of 
quaternary structures to functional protein complexes, e.g. the endosialidase of 
coliphage K1F [Schwarzer et al., 2009], fibril-forming collagen [Khoshnoodi et al., 
2006], and the von Willebrand factor (VWF) [Rosenberg et al., 2002]. The question, if 
LPH belongs to one subgroup or the other remains to be answered. Finally, the 
possibility exists that this classification does not reflect the complexity of the folding 
processes of multi-domain membrane-anchored glycoproteins. 
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4.4  Elimination of a homologous domain of an intestinal 
 hydrolase results in changed intracellular trafficking via
 altered membrane association 
 
In polarized epithelial cells, like enterocytes, two distinct domains of the plasma 
membrane do exist, the basolateral and the apical domain. The latter is the site, to 
which LPH and other hydrolases of the brush border membrane, e.g. SI, dipeptidyl 
peptidase IV (DPPIV) or aminopeptidase N (APN), are delivered. The diverse and 
heterogeneous mechanisms of apical protein transport are reviewed by [Delacour 
and Jacob, 2006] as well as [Weisz and Rodriguez-Boulan, 2009]. 
 
Live cell imaging performed to elucidate LPH and SI apical sorting mechanisms 
revealed that SI – which is associated with Triton X-100 detergent resistant 
membranes (DRMs) – and LPH – which is not DRM-associated – can be found in 
different compartments in the same post-TGN vesicle. There, SI localizes at certain 
sites while LPH is equally distributed over the vesicle surface. Subsequently, both 
proteins are separated to smaller, different transport vesicles and for the first time a 
post-TGN separation event could be detected [Jacob and Naim, 2001]. Further 
experiments showed that transport of SAVs (SI-carrying apical vesicles), but not 
LAVs (LPH-carrying apical vesicles), is actin-dependent and requires the motor 
protein myosin Ia [Jacob et al., 2003] as well as the annexin II-S100A10 complex 
[Jacob et al., 2004] and alpha-kinase 1 (ALPK1) [Heine et al., 2005]. 
For LPH and LAVs, however, it could be shown that the beta-galactoside binding 
lectin galectin-3 (gal-3) is implicated in raft-independent, carbohydrate-dependent 
glycoprotein transport. Gal-3 acts as a sorting receptor by interacting directly with 
LPH in the LAV lumen and its depletion leads to basolateral sorting of LPH [Delacour 
et al., 2006]. Moreover, without gal-3 no high-molecluar-weight clusters are formed, 
in which non-raft-dependent glycoproteins are cross-linked prior to apical sorting 
[Delacour et al., 2007]. The direct interaction of gal-3 and LPH also occurs in vivo 
confirming the previous data from MDCK cells. Interestingly, for the raft-associated 
apical enzyme DPPIV this direct interaction could also be shown. Furthermore, gal-3 
depletion results in cytoarchitectural defects of enterocytes, indicating an important 
role for this lectin not only in apical trafficking but also in epithelial morphogenesis 
[Delacour et al., 2008]. What is more, is that reduction of cellular gal-3 levels results 
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in changes in the microtubular network as well as in the membrane 
compartimentalization in vitro and in vivo. Moreover, gal-3 is transiently associated 
with the centrosome during cell differentiation and seems to be involved in 
centrosome formation and/ or stabilization [Koch et al., 2010]. It is tempting to 
speculate that – because of its connection to the centrosome – gal-3 is also 
implicated in early trafficking events, since the intermediate compartment (IC) is also 
connected to the centrosome as well as to the endocytic recycling compartment 
[Marie et al., 2009]. The question, if the differences between LPH and LPH∆4 in ER-
Golgi-transport, quaternary structure as well as membrane association are related to 
the lack of a gal-3-LPH∆4 interaction still needs to be answered. The observation 
that LPH∆4 can be found in the same vesicles as wild type LPH – and therefore is 
localized in LAVs – but does not colocalize within these carriers suggests that the 
absence of homologous domain IV rather than the difference in membrane 
association may cause a disturbed or inhibited gal-3-LPH∆4 interaction together with 
reduced or even eliminated incorporation of LPH∆4 into high-molecular.weight 
clusters. In general, galectins are known to have a variety of effects on the transport 
of proteins to their final destination [Delacour et al., 2009].  
Very recently, the kinesin motor KIF5C was found to be involved in apical sorting of 
raft-dependent and raft-independent proteins directly after TGN-release [Astanina 
and Jacob, 2010]. Subsequently, SI and LPH are transported together in the same 
vesicle transendosomally and colocalize with Rab4-, Rab8-, and Rab11-positive 
endosomes before they are segregated to distinct vesicles [Cramm-Behrens et al., 
2008]. If the absence of domain IV in LPH∆4 influences the transendosomal 
transport still needs to be elucidated. 
 
Protein-lipid and protein-protein interactions within biological membranes play key 
roles in arranging and regulating cellular mechanisms [Lindner and Naim, 2009; 
Lingwood and Simons, 2010]. For SI it could be shown that N- and O-glycosylation 
together with the localization of the enzyme in Triton X-100-DRMs enables the 
protein to become enzymatically active [Wetzel et al., 2009]. Another example is the 
PSMA protein. Here, three distinct glycoforms were identified with different 
detergents, displaying that the intracellular transport of each biosynthetic form 
happens through distinct membrane microdomains [Castelletti et al., 2008]. 
Furthermore, utilization of the mild non-ionic detergent Tween 20 made it possible to 
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discriminate apically and basolaterally sorted proteins early in the secretory pathway 
by isolation of ER-membrane enriched DRMs. By that, the existence of an early 
polarized sorting mechanism occurring before protein maturation could be proposed 
[Alfalah et al., 2005]. Although LPH and domain III are efficiently transported to the 
apical membrane of polarized cells, the possibility exists that LPH∆4 is not, because 
it is weaker associated with Tween 20-DRMs. 
Isolation and analysis of Tween 20-DRMs also suggested an early trafficking control 
for membrane proteins operating between the ER and Golgi apparatus, because an 
anchor-less mutant of the membrane dipeptidase (MDP) showed a retarded 
maturation together with complete solubility [Hein et al., 2009].  
 
Similar to the prerequisition of gal-3-dependent high-molecular-weight clusters for 
apical sorting of raft-independent glycoproteins [Delacour et al., 2007], the 
oligomerisation of raft-associated GPI-anchored proteins prior to apical transport has 
also been observed [Paladino et al., 2004]. Additionally, it has been shown by the 
same group that some raft-independent apical transmembrane proteins do not 
oligomerise before they reach the apical plasma membrane [Paladino et al., 2007]. 
Moreover, coexpression of wild type and a mutant form of the prion protein resulted 
in an altered transport rate a well as increased DRM-association of both proteins 
most likely because the mutant influences the subcellular localization and membrane 
microenvironment of the wild type protein by direct interaction [Schiff et al., 2008]. It 
would be interesting to know if the LPH-G1363S mutant (or a deletion mutant) is able 
to form dimers with wild type LPH in vitro when coepressed – imitating a 
heterozygous in vivo situation – and if this pseudo-heterodimer is transport 
competent or not. By that, the intramolecular organisation of the LPH protein and the 
strengths of its intramolecular chaperones could be further elucidated. 
Furthermore, cholesterol-dependent membrane domains exist at the apical and the 
basolateral sites of polarized cells, whereby the actin cytoskeleton is implicated in 
organizing apically sorted transmembrane proteins independently of rafts [Lebreton 
et al., 2008].  Finally, a connection between DRM-association, oligomerisation and 
apical sorting could be observed for GPI-anchored proteins. Interestingly, addition of 
cholesterol resulted in oligomerisation of a basolaterally sorted protein and 
subsequent missorting to the apical membrane [Paladino et al., 2008].  
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Taken together, the correlation of oligomerisation and membrane association in the 
context of polarized sorting is still obscure, but LPH and LPH∆4 represent valuable 
tools for further analyses.  
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6. Appendix 
 
 
6.1  List of abbreviations 
 
A alanine; adenine 
Ala alanine 
ALPK1 alpha-kinase 1 
ap apical 
APN aminopeptidase N 
APS  Ammoniumperoxidsulfate 
Aqua bidest.  Aqua bidestillata  
Arg arginine 
Asn asparagine 
Asp aspartate 
ATP adenosine triphosphate 
bl basolateral 
bp  base pair(s)  
BFA brefeldin A 
BiP binding immunoglobulin protein 
°C degree Celsius 
C cytosine 
cDNA  complementary DNA  
CFP cyan fluorescent protein 
CLD congenital lactase deficiency 
cm centimeter 
conc. concentration 
COP coat protein 
cp. compare 
CT cytoplasmic tail 
D asparagine 
D3,DIII domain III 
Da  Dalton  
dATP  deoxyadenosine triphosphate  
dCTP  deoxycytosine triphosphate  
DEAE diethyle-amino-ethyle 
dGTP  deoxyguanosine triphosphate  
DMEM Dulbecco’s modified Eagle Medium 
DMSO  dimethyl sulfoxide  
DNA  deoxyribonucleic acid  
DNAse  deoxyribonuclease  
dNTP  deoxynucleotide triphosphate  
DPPIV dipeptidyl peptidase IV 
DRM(s) detergent resistant membrane(s) 
DTT  dithiotreitol (Cleland’s reagent) 
dTTP  deoxythymidine triphosphate  
E glutamate 
E.coli  Escherichia coli  
EDTA  ethylenediaminetetraacetate 
e.g. (exempli gratia) for example 
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Endo H endo-β-N-acetylglucosaminidase H (from Streptomyces  
         plicatus) 
Endo F endo-β-N-acetylglucosaminidase F (from Flavobacterium 
        meningosepticum) 
ER endoplasmic reticulum; Endoplasmatisches Retikulum 
ERAD ER-associated degradation 
et al.  et alii  
evtl. eventuell 
F phenylalanine 
FCS fetal calf serum 
Fig.  figure  
g  gram(s)  
x g accelaration of gravity 
G glycin; guanine 
GA Golgi apparatus; Golgi-Apparat 
Gal galactose 
gal-3 galectin-3 
GalNAc N-acetyl-α-D-galactosamine 
GE Germany 
GFP green fluorescent protein 
GH glycosyl hydrolase 
Glc glucose 
GlcNAc N-acetyl-glucosamine 
Glu glutamate 
Gly glycine 
GPI glycosyl-phosphatidylinositol 
GT galactosyl transferase 
h  hour(s)  
HPLC high-performance liquid chromatography 
Hsp70  heat shock protein 70  
ic intracellular 
IC intermediate compartment 
i.e. id est 
IgG  immunoglobulin G  
k  kilo  
K lysine 
kb  kilo base pair(s)  
kDa  kilo Dalton  
KOAc potassium acetic acid 
l  liter  
L leucine 
LB  Luria Bertani 
ld liquid-disorderd 
Leu leucine 
lo liquid-ordered 
LPH lactase phlorizin hydrolase (all forms) 
lys lysate 
Lys lysine 
M  molar  
m  milli  
µ  micro  
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mA milliampere 
mAb monoclonal antibody 
MA membrane anchor; Massachusetts 
Man mannose 
MDCK Madin Darby Canine Kidney 
MDP membrane dipeptidase 
med medium    
MEM Minimum Essential Medium 
Met methionine 
mg milligram 
min  minute(s)  
ml  milliliter  
µl microliter 
mM millimolar 
mRNA  messenger RNA  
n  nano; nucleus  
N asparagine 
NaCl sodium cloride 
NAD  nicotine amide dinucleotide  
NaOAc sodium acetic acid 
NGF nerve growth factor 
NSF N-ethylmaleimide-sensitive factor 
OD
xxx  
optical density at xxx nanometers  
ORF  open reading frame  
OS(P)T oligosaccharide (protein) transferase 
p  pico; pellet 
P proline 
pAb polyclonal antibody 
PAS protein A-sepharose 
PBS phosphate buffered saline 
PCR  polymerase chain reaction  
PDI protein-disulfide isomerase 
PH phlorizin hydrolase 
Phe phenylalanine 
PMSF  phenylmethylsulfonyl fluoride  
PPI peptide-prolyle isomerase 
Pro proline 
PSG penicillin, streptomycin, glutamine 
PSMA prostate-specific membrane antigen 
Q glutamine 
R arginine 
RNA  ribonucleic acid  
RNAse  ribonuclease  
rpm  rounds per minute  
s supernatant 
S serine  
SDS sodium dodecyl sulfate 
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel electrophoresis  
sec  second(s)  
Ser serine 
SI sucrase isomaltase 
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SNAP soluble NSF attachment protein 
SNARE SNAP receptor 
SRP signal-recognition particle 
SS signal sequence 
T thymine 
TAE Tris acetate EDTA 
TE Tris-EDTA 
TEMED N,N,N’,N’-tetramethylethylendiamine 
TGF transforming growth factor 
TGN trans-Golgi network 
Thr threonine 
Tris Tris-hydroxymethyl-aminomethane 
U  unit  
UDP uridine diphosphate 
UK United Kingdom 
USA United States of America 
UV  ultraviolet  
V  volt  
v/v  volume by volume  
VWF von Willebrand factor 
w/o without 
w/v  weight by volume  
WT;wt  wild type  
Y tyrosine 
YFP yellow fluorescent protein 
®  registered trademark  
                                                                                                                    Appendix 
127 
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